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Chapter I
INTRODUCTION AND REVIEW OF RELATED LITERATURE

2
Rationale and Objectives
The bone marrow is the primary site of blood cell production, or hemopoiesis,
in post natal mammals. Blood cells develop within the marrow in association with other,
nonhemopoietic cell types; including, endothelial cells, reticular cells, osteoblasts, and
bone lining cells.

Some of these nonhemopoietic cells are believed to provide the

supportive microenvironment for blood cell development. This microenvironment can
be at least partially reconstituted in long-term bone marrow cultures, allowing blood cells
to be produced in vitro for several months. Hemopoietic differentiation in these cultures
is dependent on the presence of a large adherent cell called a stromal cell. Stromal cells

in vitro express adhesion molecules that serve to bind the hemopoietic precursors to the
stromal cell surface. Inhibition of direct contact with stromal cells ablates hemopoiesis
in culture.

As well, stromal cells produce a variety of cytokines that can influence

hemopoietic development. These facts argue that stromal cells play a pivotal role in
controlling blood cell development. However, in vitro derived stromal cell lines are
heterogeneous by several criteria, raising questions about the phenotype and function of
the stromal cell counterpart in the marrow. Alternative hypotheses of distinct stromal
cell subsets performing different functions versus a single cell type with a highly plastic
phenotype have been proposed. The best avenue to study the biologic activity of any cell
type is to study it in vivo. However, there is no discrete marker of stromal cells to
identify and study them in vivo. The aims of this dissertation are to identify and enrich
stromal cells directly from bone marrow cell suspensions using a combination of less
specific markers that have been described and examine their role in supporting lymphoid
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differentiation through the production of cytokines. These studies are singular in their
attempt to study stromal cells without in vitro culture and will provide a much needed
link between in vitro and in vivo studies of hemopoiesis. The availability of normal,
uncultured stromal cells is needed to understand the ways in which they regulate
hemopoiesis and are themselves regulated by the requirements of the organism. Such
studies are important to begin analyzing the basis of hemopoiesis and the ways it can go
awry, as in leukemia, hemopoietic dysfunction, and autoimmunity.

I. Overview of Hemopoiesis
Blood cells must be continually replaced because they have a finite lifetime in the
circulation. Red blood cells gradually lose their integrity, platelets are lost with even
minor blood loss, and myeloid cells are destroyed in defending the organism against
invading pathogens. It is estimated that the entire pool of red blood cells in the body
must be replaced every 120 days and granulocytic cells have a lifespan in the circulation
of only 6 to 7 hours (1). Hemopoiesis is the process by which these distinct lineages of
blood cells are produced from a common precursor.

Hemopoiesis starts in 'blood

islands' of the embryonic yolk sack, then migrates to the fetal liver, and subsequently to
postnatal bone marrow (2). While the marrow remains the exclusive site of hemopoiesis
normally, in times of stress, such as bone marrow failure, hemopoiesis can move again
to the spleen or liver (extramedullary hemopoiesis)(3). In mouse the marrow of the long
bones, e.g. femur, remains hemopoietic through adulthood, whereas in humans the
volume of hemopoietic marrow generally decreases with age, being confined to the flat
bones of the ribs, sternum, vertebrae, and iliac crest (4).

Nonhemopoietic marrow
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accumulates fat, consequently being called yellow marrow (4).

Again, in time of

increased hemopoietic demand, this yellow marrow will convert back to red, actively
hemopoietic, marrow (3).
Hemopoiesis is a normal, homeostatic process and, as such, must be tightly
regulated. Aberrations in hemopoiesis can be quite severe, ranging from anemia caused
by a deficit in erythrocyte synthesis to leukemia caused by unrestricted growth of
lymphocytic or myelocytic cells or their precursors. In these examples, the results of
aberrant regulation show that either decreased or increased production of blood cells can
be equally detrimental to the individual.

A normal physiologic example of such

regulation is found in the production of red blood cells.

Erythrocyte formation was

found to be regulated by a circulating factor as long ago as 1906 (5), a factor now known
as erythropoietin (EP0)(6). Lowered oxygen tension in the blood is sensed by cells in
the kidney, prompting them to release EPO into the circulation where it travels to the
marrow to stimulate erythroid progenitors (7). Similarly, the inflammatory cytokine IL-1
has been found to affect the release of granulocytes from marrow reserves (8) and could
indirectly cause increased proliferation of myeloid progenitors (9-15). In addition to
control via the circulation, the marrow is innervated, potentially rendering it sensitive to
direct stimulation from the nervous system (16-19). Webber and colleagues showed that
electro-stimulation of the lumbar trunk in rats led to increased release of reticulocytes,
neutrophils, and lymphocytes from the marrow (20,21).

A. Stem Cells
The common precursor cell from which all hemopoietic lineages arise is called
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a pluripotent hemopoietic stem cell (PHSC).

The PHSC is the pinnacle of the

hemopoietic hierarchy. A unique property of the PHSC is its capacity for self renewal,
that is, the stem cell compartment remains constant throughout the lifetime despite
continuous division of the PHSC to generate new blood cells (22,23). PHSC divide very
slowly but their immediate progeny undergo extensive proliferation, increasing the
number of cells entering hemopoietic differentiation pathways. These rapidly dividing
daughters of the PHSC retain their capacity to differentiate into many types of blood
cells. The PHSC daughters and their progeny form a progression of cells with slightly
differing proliferative capacity and gradually restricted differentiation options. These
cells enter into lineage specific differentiation pathways, eventually forming the
morphologically-identifiable stages of hemopoietic development characterized in the
marrow (22).
Defining the PHSC has been a long-standing, yet elusive, goal of many
researchers.

A variety of methods have been used to isolate and functionally define

PHSC. Cell surface markers often used to enrich mouse PHSC include Thyl, c-kit,
AA4.l, SCA-1 (Ly6A/E), CD4, and binding of wheat germ agglutinin (yVGA) (22).
However, these markers are not exclusive to PHSC so rather complicated,
multiparameter cell separations have been employed. Purification of human PHSC is
typically based on their expression of the CD34 antigen (22). Equally important is the
assay system used to detect PHSC (23). The first definition of stem cell activity was the
capacity to form colonies of hemopoietic cells on the spleen (CFU-S) of lethally
irradiated animals (24). However, it has recently become clear that CFU-S represent a
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more restricted type of hemopoietic cell, not capable of resulting in long-term
repopulation of the recipient's hemopoietic organs, the true measure of a PHSC (23).
Recently, a novel way of assessing stem cell activity without the extended time required
for reconstitution of an irradiated animal was developed. In this assay cells are placed
in contact with a feeder layer of adherent bone marrow cells.

Very primitive

hemopoietic precursors and putatively even PHSC will proliferate in the cultures,
forming foci of cells attached to the adherent cells. The amount of time in culture
required for such proliferating cells to appear correlates with their hemopoietic
primitiveness (25 ,26,27).

B. B Lymphocyte Development
B lymphocytes, the cells which produce antibody (immunoglobulin, lg) molecules,
are a lineage of hemopoietic cell produced within the bone marrow from PHSC. Unique
antibody molecules are assembled during B cell differentiation by the rearrangement of
gene segments encoding the antigen combining site of the antibody molecule (28). The
hallmark of B cells is expression of the B220 cell surface antigen (CD45RA) which
marks all B lineage committed cells in the bone marrow (29,30). Immediately before
expression of B220 on the cell surface, the enzyme terminal deoxynucleotidyl transferase
(Tdn is expressed in the nucleus. This enzyme is thought to mediate addition of Nregion nucleotides into the junctions oflg heavy chain (IgH) rearrangements (31). After
functional rearrangement of an IgH allele is complete the IgHµ chain is expressed in the
cytoplasm of the cell (cµ +) and is detectable by immunofluorescence (32). Interleukin-7
is a central growth factor in B cell development.

Early cells immediately after
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expression of B220 (CD45RA) require the presence of accessory stromal cells and IL-7
for survival (33). Somewhat more mature cells that have begun to express cµ can
proliferate in response to IL-7 alone (34,35). Since there is extensive cell loss at the
rearrangement steps, it is thought that IL-7 mediated proliferation serves to expand the
number of cells entering the stage of lg light chain (lgL) rearrangement (31). As well,
it has been suggested that expression of the functionally rearranged lgH chain complexed
with the surrogate-light chain molecules A5 and VpreB is necessary to continue
differentiation (36).

Other cytokines, c-kit ligand (also called SCP, MGF,

SlF)(37,38,39, this dissertation) and insulin-like growth factor-1 (IGF-1)(40, this
dissertation), can also impact on B lineage differentiation.

Upon successful

recombination of light chain alleles a functional lg molecule can be expressed on the cell
surface.

The B cell can then be called an immature B lymphocyte.

maturation the cell will express lg molecules of both µ and

With further

oisotypes, both containing

identical antigen combining sites, and exit the marrow for the secondary lymphoid organs
(31). Detection of each of these stages of B cell development is possible, making it
feasible to dissect the differentiation pathway stage by stage (30,32-35).

II. The Microenvironment
All lineages of blood cells originate in the marrow but there is no obvious
functional or structural separation into compartments as in other tissues; cells of all
lineages are seen scattered throughout the marrow. The bone marrow has been described
as, "free-living cells, not constrained by organ defining structures, such as basement
membranes, required where specific anatomical relationships underline function. "(41)

8
Only a gross level of order has been found in bone marrow, Lord et al. (42,43) found
that CFU-S are found preferentially in peripheral marrow, closer to the bone surface.
Similarly, Osmond et al. (44) and Hermans et al. (45) found the earliest B cell
precursors chiefly in peripheral location in the marrow. To explain this indiscriminate
structure, Trentin and colleagues proposed the microenvironmental hypothesis (46).
Their hypothesis holds that developing blood cells respond to local influences rather than
responding directly to systemic signals. These local influences act over a very short
radius, allowing many types of cells to be produced in close apposition to one another
within one organ. It is these local signals, or microenvironments, that determine the fate
of particular blood cells.
Evidence supporting the microenvironmental hypothesis is found in some natural
mutations of the mouse. One of the most recognized of these is the Sl (Steel) mutation.
This animal has a severe macrocytic anemia, affecting many lineages of blood cells, as
well as defects in coat color and gamete formation (47,48). Although the anemia is
clearly caused by defective hemopoiesis, transplantation of stem cells from normal mice
does not cure the anemia (48). Additionally, transfer of stem cells from Sl mutants into
irradiated normal animals results in repopulation of the recipients with donor (SI) type
cells (48,49). These defects are duplicated in in vitro bone marrow cultures (50). These
experiments demonstrate that the hemopoietic cells themselves behave normally but that
something intrinsic to the animal's bone marrow prevents normal hemopoiesis.
Transplantation of long-term cultured stromal cell lines derived from normal animals to
replace the Sl microenvironment, however, does cure the SI anemia, verifying that it is
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the microenvironment that is defective (51). The defect in these animals resides in the
gene for c-kit ligand (also called SCP, MGP, SIP), a growth factor now known to affect
a wide variety of hemopoietic cells (52-58). C-kit ligand can be presented as an integral
membrane protein as well as secreted into the microenvironment (54,59,60).
The marrow microenvironment can be roughly subdivided into three broad
constituents; cells, growth factors, and extracellular matrix (61).

The cellular

component principally refers to the non-hemopoietic mesenchymal cells which form a
three-dimensional network supporting and, according to current thought, orchestrating
development of blood cells (61,62), as well as blood cells which can reenter and reside
in the marrow. The exact components of the cellular microenvironment will be discussed
in detail below. Growth factors are proteins secreted by cells which can mediate effects
on target cells when bound to their cognate receptors. Such effects include proliferation,
alteration in gene expression leading to differentiation, or suppression of proliferation
and/or differentiation. In addition, many hemopoietic cells express receptors for more
than one type of growth factor. The interaction of factors simultaneously can cause a
different response than the factors would separately, often exaggerating the effect in a
synergistic fashion.

Such interaction adds to the complex interplay of hemopoietic

development. The extracellular matrix (ECM) is composed of protein, proteoglycan, and
glycosaminoglycan molecules secreted by cells within the marrow cavity. Hemopoietic
cells are able to adhere to the ECM via specific receptors and, on binding, these
receptors can convey inductive signals to the cells as well as information about the cell's
position. Also, secreted growth factors can be bound to ECM components, enabling the
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growth factor signal to be precisely localized and imbued with information from
surrounding ECM and cellular microenvironmental components (61,63,64).

The

interplay of these elements can be quite complex, with the end result being the careful
orchestration of blood cell development and its attunement to physiologic need.

A. Marrow Structure and the Cells of the Microenvironment
Structurally, mature marrow is composed of an outer sheath of bone remodeling
and lining cells and an inner core of hemopoietic tissues drained by a lattice of venous
sinuses.

Hemopoietic cells develop supported by a three dimensional network of

processes formed by reticular cells (65). The structural cells of the marrow which do
not develop into blood cells are collectively referred to as stroma.

These include

endothelial cells, reticular cells, bone lining cells, osteoclasts, and osteoblasts. Blood
supply to the marrow enters through a nutrient canal. From this vessel, ascending and
descending arteries branch out toward the cortical bone. These vessels subsequently
reenter the marrow, collecting into the venous sinuses which drain into the central sinus
which exits the marrow again via the nutrient canal (61). Nerve fibers run along the
circulation to regulate the smooth muscles lining the arteries (61). A number of efferent
nerve fibers contact periarterial adventitial cells via gap junctions. Such complexes,
called the neuroreticular complex, appear capable of transducing signals form the nervous
system, although their function remains unexplored (19).
Endothelial cells line the sinusoids which permeate the marrow and serve to
regulate the exit of newly formed cells from the marrow (8,61). These cells are not
connected by tight intercellular junctions and this is thought to be a special characteristic
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of marrow endothelial cells. Specific factors are believed to affect the release particular
cell types. For instance, the C3e component of complement is thought to cause the
release of granulocytes.

The inflammatory cytokine IL-1 also appears to promote

granulocyte release, and EPO has been implicated in the release of reticulocytes (8). In
addition to regulating cells leaving the marrow, endothelial cells in vitro are capable of
producing hemopoietic cytokines (IL-6, G-, M-,and GM-CSF) and could possibly
contribute these to the microenvironment in vivo (63). Treatment of endothelial cells in

vitro with IL-1 or TNF leads to increased transcription of the genes for colony
stimulating factors, so production of these hemopoietic cytokines could be tied to the
circulating levels of cytokines (9, 10, 11).
One of the main types of nonhemopoietic stroma cell in the marrow is the
reticular cell. Two types of reticular cells have been described in bone marrow, both of
which express the enzyme marker alkaline phosphatase (66,67). Adventitial reticular
cells line the abluminal side of venous sinusoids and extend reticular processes into the
marrow. These cells may be contractile, regulating access of maturing blood cells to the
endothelium for subsequent exit from the marrow (66).

Fibroblastic reticular cells

remain fixed within the marrow and predominate in the endosteal areas. Both cells
possess oval or rounded nuclei with prominent nucleoli and extend numerous cytoplasmic
processes away from the cell body (66). These processes intimately contact hemopoietic
cells forming a "spongework" that physically supports them (65). This intimate contact
and the possible contractility of adventitial reticular cells has led some to speculate that
these cells can actively trap hemopoietic cells and induce their differentiation (65). Both
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types of reticular cells appear to have large amounts of rough endoplasmic reticulum,
indicative of active protein synthesis for secretion. Reticular cells are associated with
fibers of collagens I and III in vivo. Both adventitial and fibroblastic reticular cells cans
accumulate lipid under certain experimental conditions (4,65,66). Mature adipocytes in
the marrow are commonly seen in a parasinal position, making it likely that adventitial
reticular cells are capable of becoming adipocytes (8).

Unfortunately, no specific

markers of marrow reticular cells are available so it has not been possible to identify
reticular cells in vitro and determine if they influence hemopoiesis in culture.
Nevertheless, observational evidence indicates that adventitial and fibroblastic reticular
cells in the marrow maintain intimate contacts with hemopoietic cells and may impact on
hemopoietic cell development.
Macrophages, although hemopoietic in origin, reside in the marrow where they
are thought to play an important role in blood cell development, particularly in
phagocytosing expelled nuclei from reticulocytes (62,65) and B cell precursors that have
presumably undergone aberrant lg gene rearrangements (68).

Resident marrow

macrophages are easily identifiable by their abundant phagolysosomes (62). Resident
marrow macrophages are often dendritic in appearance, extending cytoplasmic processes
out to contact developing erythroid cells in a formation known as an erythroblastic island
(62). Cultured marrow macrophages have been implicated in regulating the terminal
stages of B cell development (69,70), however macrophages in situ are seldom seen
associated with lymphoid cells (62). Macrophages are well known as producers of a
wide variety of cytokines and hemopoietic growth factors, including M-, G-, GM-CSF,
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IL-1, 3, 6, 8, TNF, and, according to a controversial study by Vogt, EPO (63,71,72).
The endosteal layer, which separates the marrow from the inner surface of the
bone, contains an enigmatic cell type called the bone lining cell (73). Bone lining cells
are found adjacent to the bone, particularly in heavily trabeculated bone. These cells are
morphologically unremarkable, described as elongated and flat with a spindle-shaped
nucleus. Dramatic changes occur in the bone lining cells upon treatment of an animal
with IL-1. These cells become highly proliferative and will move into the marrow
enveloping putative stem cells, interacting with developing hemopoietic cells, and
replacing the adventitial reticular cells covering the endothelial lining of the venous
sinusoids (74). Bone lining cells may influence early steps of hemopoietic development
as they lie in a region known to be rich in CFU-S and primitive B cell precursors (42-5).
In addition, Chan and Metcalf reported that bone lining cells are a potent source of
colony stimulating factors (75).

It has been suggested that bone lining cells may

represent a form of mesenchymal stem cell which can generate the hemopoieticsupportive stroma.
Also in the endosteum are osteoblasts and osteoclasts, the cells responsible for
forming and resorbing bone, respectively.

Based of staining with a variety of

macrophage specific monoclonal antibody reagents (76) and their dependence on M-CSF
(77), osteoclasts may be hemopoietic cells similar to, but distinct from, macrophages
(78, 79). Osteoblasts develop from precursors in the endosteum and, once differentiated,
are characterized by strong expression of alkaline phosphatase and the bone matrix
proteins osteopontin and osteocalcin (80,81). Osteoblasts produce collagens I and III (82)
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and may release IGF-1, a stimulator of hemopoietic cells, into the marrow
microenvironment (78). These data indicate that osteoblasts, cells thought to be solely
involved in the production of bone, may also impact on microenvironmental interactions
in the marrow.
In summary, the marrow contains several cell types which are found in close
apposition to developing blood cells and, therefore, could form part of the
microenvironment that influences blood cell development.

These include endothelial

cells, reticular cells, macrophages, bone lining cells, and osteoblasts.
Although bone and bone marrow have evolved separately, there is good reason
to suspect a unique relationship between these organs (78). The formation of marrow
appears to be inextricable from the generation of bone. Even bone formed at ectopic
sites or in vitro will be hollowed out and filled with hemopoietic marrow (83-87). The
activity of these two organs is similarly entwined.

Guilliani reported that hypoxia

resulted in an increase in marrow volume and consequent decrease in bone mineral
density (88). In the human diseases sickle cell anemia and thalassemia, the marrow is
very active but the bone becomes osteopenic, with fractures being a common
complication of the disease (89-92). Yellow marrow appears to become hemopoietically
active during repair of bone fractures as well (78). When bone formation is slowed, as
in space flight or in paraplegic individuals, hemopoiesis is reduced (93-95).
Autoradiographic evidence suggests that the mesenchymal cells which produce the
reticular marrow stroma may also become osteoblastic cells (83).
The origin of the microenvironmental cells has been the subject of some
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controversy. The weight of the evidence suggests that microenvironmental cells arise
from precursors outside of the hemopoietic lineage (96-98).

In studies on the

transplantability of the microenvironment Simmons et al. reported, "Without exception,
marrow derived stromal cells . . . were found to be of host genotype" (98). Using
autoradiography to study marrow histogenesis, Sahebekhtiari and Tavassoli found
"complete dissociation of marrow stroma and hemopoietic stem cells" (83). Nonetheless,
a few investigators have maintained that the cells of the microenvironment are formed
from hemopoietic stem cells. Huang and Terstappen recently isolated CD34+ cells from
human cord blood and reported that single cells could form both a microenvironment and
hemopoietic cells in vitro (99). This may reflect a specialized case for fetal cells or they
may have isolated phenotypically similar cells that nevertheless have distinct
differentiation potentials (100). Work by Simmons et al. indicates that human marrow
stromal cell precursors express the CD34 antigen but did not determine if these cells
made hemopoietic cells as well (101).
Evidence suggests that the nonhemopoietic cells of the marrow arise from a
common mesenchymal stem cell. Several authors have used regenerating marrow or
marrow formation in ectopically implanted bone to study the histogenesis of the marrow
stroma (83-87).

When the marrow cavity is initially formed a group of rapidly

proliferating fibroblastic cells appears. Autoradiographic labelling indicates that these
cells continue to divide for a time, producing osteoblasts in the endosteum and
endothelial and reticular cells present within the marrow parenchyma (83). Unfortunately
these fibroblastic precursors are rather unremarkable, being described as star-: or spindle-
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shaped with delicate chromatin pattern and two or more nucleoli (83). To date there are
no reports of specific identification of these cells. However, Grigoriadis et al. have
isolated a clonal cell line from fetal rat calvaria that, when cultured with differentiation
inducers such as ascorbic acid or dexamethasone, can differentiate into cells of muscle,
fat, cartilage, and bone (102).

This cell line may reflect the presence of such a

multipotential mesenchymal precursor in the developing bone marrow, but its capacity
to support hemopoietic differentiation has remained untested. As well, Freidenstein has
found cells derived from the bone marrow which possess the potential to become
osteogenic (103). Further examination of such mesenchymal precursors is warranted to
understand the developmental process of bone and bone marrow.

B. In Vitro Models of the Hemopoietic Microenvironment
The role of nonhemopoietic cells in forming the microenvironment was suggested
by the close association of developing blood cells with thin cytoplasmic processes of
nonhemopoietic cells in the marrow as seen by both light and electron microscopy
(61,62,65,67,68). This supposition was strengthened dramatically with the development
of long-term bone marrow cultures (LTBMC).

In the late 1970's Dexter and

coworkers discovered that it was possible to reproduce the mouse bone marrow
microenvironment, at least partially, in vitro (104). By using carefully controlled culture
conditions, including horse serum, hydrocortisone, and 33°C incubation temperature, it
was possible to derive cultures that both maintained primitive stem cells and allowed the
continuous differentiation of myeloid lineage hemopoietic cells. With regular medium
replacement these long-term bone marrow cultures (LTBMC-M) could continue to
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produce myeloid cells for several months in vitro. Whitlock and coworkers subsequently
devised a culture system which supported long-term B lymphopoiesis (LTBMCB)(105,106). Each of these conditions has been further modified for use with human
marrow samples, with limited success (107, 108). In these culture systems, long-term
hemopoiesis is dependent on the formation of a complex adherent layer of cells. Under
LTBMC-M conditions this adherent layer includes macrophages, adipocytes, endothelial
cells, and a cell often referred to as a blanket cell, whereas LTBMC-B adherent layers
are composed almost exclusively of macrophages and an ill-defined, highly spread
adherent cell (3,63,64,104-106,109-111). Developing hemopoietic cells in both culture
systems are seen attached to these large, highly spread adherent cells which have come
to be called stromal cells.

ID. Stromal Cells
The large adherent cells in these cultures have been the subject of scrutiny
because of their apparent intimate involvement in hemopoietic development. Inhibition
of the physical contact between hemopoietic cells and stromal cells by either diffusion
chambers or antibodies to adhesion molecules prevents development of the hemopoietic
cells ( 112-119). These cells have also been shown to produce a variety of growth factors
thought to be important in hemopoiesis (3, 12, 15,63,64, 120-124). Several groups have
adopted a reductionist approach to the study of stromal cells, deriving cell lines in hopes
of reconstructing in vitro the minimal requirements for hemopoiesis (3,64, 125-136).
However, such studies have revealed surprising heterogeneity among stromal cell lines
and with primary LTBMC stromal cells. The term stromal cell has come to refer to any

Table 1. -- An Example of a Stromal Cell Classification Scheme Based on Properties of Cloned Cell LinesStromal Cell
Subtype

Collagen Types

Fibronectin
Laminin

Alkaline
Phosphatase

Stem Cell Support
in Culture

EndothelialAdipose

I, IV, V

++

±

+

Fibroblast

I, III

+

++

Endothelial-like

IV, V

+

+

Fibroendothelial

I, III, IV, V

+

+

--

and

Macrophage
• As proposed by Zipori (137).

00
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nonhemopoietic adherent cell derived from bone marrow; cells with widely differing
properties also described as stellate, fibroblastoid, endothelial-like, epithelioid, and
fibroendothelioid among others (110). Zipori has proposed a classification scheme for
cultured stromal cell lines based on their production of extracellular matrix components,
hoping to correlate stromal cell lines with cells found normally within the marrow (Table
1)(137). Although well intended, this scheme has probably only furthered the confusion
over the lineage derivation of cultured stromal cells as it is not universally applied.
Many groups refer to their stromal cells as fibroblastic based on morphology without
examining their extracellular matrix production.

Additionally, the morphologic

definitions used can vary considerably from laboratory to laboratory. The functional
relevance of stromal cell lines to normal cells in the marrow is also questionable. Cells
described as fibroblastic are commonly cultured from marrow, although there may be
few fibroblasts present in the hemopoietic spaces since most fibroblasts are associated
with vascular channels (8).

Therefore the cultured marrow fibroblasts commonly

reported may be from blood vessel derived cells or rare unassociated fibroblasts and any
hemopoietic support function seen in vitro could be artifactual or a minor aspect of
normal hemopoiesis in the marrow.
A. Primary Culture

Stromal cells in primary LTBMC cultures appear homogeneous in several
features, notably their characteristic large size and oval nuclei with many nucleoli, the
production of collagens I and IV, laminin, and display of the cell surface antigens MECA
10, VCAMl, CD44, and 8.28 (96,110,111,121,132). Primary cultured stromal cells do
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not endocytose the acetylated form of LDL, phagocytize latex beads or lg-coated red
blood cells, or express the common leukocyte antigen (CLA) and macrophage cell
surface markers (110). These cells express a smooth muscle specific isoform of actin,
although it has been suggested that it is present only when the cells are proliferating
(138-140). Simply interpreted, the stromal cells seem to be neither fibroblasts nor
endothelial cells, but may be related to pericytes, myofibroblasts, or smooth muscle cells.
Many groups believe that they are equivalent to the adventitial reticular cells (64).
These, as well as endosteal reticular cells, express alkaline phosphatase in vivo (66,67).
Such apparent homogeneity might reflect only a single cell type mediating all
hemopoietic support functions in vivo. This single cell could then alter its phenotype in
response to environmental changes, consequently altering the number and type of blood
cells produced. The ability to switch stromal cell layers from LTBMC-M to LTBMC-B
conditions with ensuing production ofB lymphocytes on the pre-formed stromal cell layer
would appear to support the contention that there is only a single stromal cell type (141).

B. Stromal Cell Lines
As stated previously, many groups have produced stromal cell lines in attempts
to understand stromal cell function. A variety of methods have been used to generate
these lines, including both repeated subculture (128-136) and direct transformation (125127). Such cell lines have been helpful in the discovery of new hemopoietic growth
factors, such as IL-7, IL-11, and kit ligand (63), and analysis of adhesion mechanisms
used by hemopoietic cells (113-117). However, this method has distinct traps in equating
a cell line with normal cells present in the marrow. First, transformation of cells often
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leads to regression to a fetal phenotype (126). Second, since we envision stromal cells

in vivo as responding to external stimuli in the regulation of hemopoiesis it is possible
that their phenotype in vitro could change considerably in reaction to subtle changes in
culture conditions. Third, the cloning process could select for rare cells in the starting
population.

These problems make it difficult to ascertain if stromal cell lines are

representative of any, or even some, of the cells normally present in the marrow.

C. Heterogeneity Among Stromal Cells
1. Cell Surface Phenotype
Although stromal cells in primary culture appear homogeneous, stromal cell lines
exhibit a great deal of diversity. For instance, the Thyl antigen is not expressed by
primary cells but does appear on some cell lines (3). Some cell lines have been reported
to express the common leukocyte antigen (CLA, 1'200, CD45) or even the pre-B cell
aminopeptidase recognized by mAb BPl (132, 133). Selected cells have the capacity to
accumulate lipid in vitro, but again this is not a universal trait (129, 130, 134).
Adventitial reticular cells, commonly thought to be the in vivo equivalent of stromal
cells, express alkaline phosphatase activity (66,67), as do a portion of the stromal cells
in LTBMC-B (142). However, alkaline phosphatase, as well as reactivity with other
histochemical stains varies among stromal cell lines (129). In contrast to stromal cells
in primary culture, which have a seemingly uniform cell surface phenotype, stromal cell
lines are highly variable, making it difficult to determine if the stromal cell lines are
aberrant from the primary cells or represent the outgrowth of minor components of the
primary culture population.
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2. Hemopoietic Sup_port
Surprisingly, even the ability to support hemopoietic development varies among
stromal cell lines (3,64, 132). Some groups have isolated cell lines capable of supporting
both myelopoiesis and lymphopoiesis in vitro, suggesting that only one stromal cell type
need be present in vivo (131,135). That cell could then modulate its activity in response
to environmental cues (141). This view is also supported by the fact that LTBMC-M
cultures switched to LTBMC-B conditions will convert to long-term production of B
lineage cells. The converse is not true because LTBMC-B cultures do not maintain the
primitive precursors needed to initiate myelopoiesis in culture.
however, are more selective in hemopoietic support (127, 128).

Other cell lines,
Dorshkind and

coworkers have isolated cell lines which support selected stages of B cell development;
Sl7 supports to generation of pre-B cells from early progenitors in the marrow while SlO
supports the differentiation of slg+ B cells from pre-B cells (127,143). The existence
of such cell lines has led to speculation that such functionally distinct subtypes are
present in vivo alongside other conclusions that a single stromal cell type can support all
lineages and stages of hemopoiesis. Again, heterogeneity among stromal cell lines has
led to apparently conflicting experimental results, making conclusions about the nature
of stromal cell support in vivo difficult to draw.
3. Stromal Dependent Stages of Hemopoiesis
Evidence exists that only particular stages of hemopoietic development require
stromal cell contact. Hardy and coworkers used multiparameter cell sorting to dissect
early stages of B cell development and found that very early cells required both contact
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with stromal cells and IL-7 whereas later cell type needed only IL-7 to proliferate in
culture (33).

Similarly, Kierney and Dorshkind showed that lymphoid progenitors

capable of initiating lymphopoiesis in culture required physical interaction with stromal
cells (112) while Lee et al. found that cells produced in culture can respond to IL-7 alone
in semi-solid medium (34). The jumbled scattering of cells in bone marrow has made
it difficult to examine such preferential associations in vivo. Crocker and Gordon, in
attempts to study resident bone marrow macrophages, isolated multicellular clusters from
murine marrow suspensions (144).

Such clusters, in addition to being enriched in

macrophages and fibroblastic cells, are enriched in colony-forming cells responsive to
GM-CSF.

This indicates, at a rough level, an association between early myeloid

progenitors and resident macrophages and fibroblasts. Working with human marrow
aspirates, Blaszek and colleagues described a structure containing a central adipocyte
which serves to organize developing hemopoietic cells which are tightly adherent to it.
They termed this unit a Hematon, suggesting that it was centrally involved in
hemopoietic cell development (145).
4. Adhesion Molecules on Stromal Cells
Adhesion between hemopoietic cells and stromal cells in vitro has recently been
the subject of intense study (112-117,146). Studies by Miyake et al. have resolved two
molecules expressed by stromal cells that are involved in sequestering B cell precursors
(113,114,116,117). The first is Pgp-1 (CD44) which is capable of adhesion to the
extracellular matrix component hyaluronate (114, 117). The addition of antibodies to
Pgp-1 to LTBMC will inhibit hemopoiesis in culture if present at the initiation of culture.
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Pgp-1 is present on >90% of murine bone marrow cells. Another stromal cell molecule
identified by Miyake et al. was Vascular Cell Adhesion Molecule 1 (VCAMl)(l 13, 116).
Jacobsen et al. have reported the presence of VCAMl on reticular cells within bone
marrow as well as some marrow endothelial cells (147). A counter-receptor for VCAMl
is VLA-4, which is expressed on >90% of bone marrow cells. Antibodies to either
VCAMl or VLA-4 will inhibit in vitro hemopoiesis even if added after the cultures are
actively producing blood cells. This strongly implicates the interaction of VCAMl/VLA4 in mediating the contact between stromal cells and hemopoietic cells.
VCAMl was initially characterized and cloned from endothelial cells. VCAMl
is a member of the immunoglobulin-like family of adhesion receptors, existing in either
of two forms containing either 6 or 7 lg-like domains (148, 149).

VCAMl is not

constitutively expressed on endothelial cells, rather it is upregulated 2 to 4 hours after
exposure of the endothelium to inflammatory cytokines such as IL-1 or TNF. When
expressed on inflamed endothelium, VCAMl serves to hold circulating leukocytes,
allowing them to eventually migrate into tissue to fight infection. VCAMl has also been
reported to be expressed on dendritic cells in the lymph node and skin and on synovial
cells in inflamed joints (150).

VCAMl is a well known adhesion molecule that is

expressed on cultured stromal cells and has been strongly implicated in their hemopoietic
support function. Its expression on stromal cells in the marrow could represent a marker
useful for analyzing fresh stromal cells without the complications that have surrounded
work on stromal cell lines.

5. Cytokine Production by Stromal Cells
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Stromal cells in vitro are known to produce several growth factors which affect
hemopoietic development (3,12,15,38,39,40,63,64,120,121,122,143,151). This is one
of the most important lines of evidence suggesting that stromal cells influence
hemopoietic cell development. Not only do stromal cells constitutively express several
growth factors, they are able to modulate growth factor production in response to
external stimuli; such as changes in culture conditions (141,152), addition of lithium
(153), or the presence of IL-1 (12,15).

Again patterns of specific growth factor

production vary among cell lines (3). However, transcription of several cytokine genes
does not appear to change in LTBMC-B cultures switched to M conditions (154). This
would suggest that cytokine production is not the primary means by which stromal cells
might regulate production of different hemopoietic cell lineages. IL-3 stimulates early
hemopoietic cells and is thought to be involved in stem cell maintenance. However, only
one group has been able to detect IL-3 transcripts in stromal cells (63). Other groups
have produced cell lines which maintain stem cells in vitro with no evidence of IL-3
production (155). Evidence such as this has led Dexter to suggest that, although growth
factors influence hemopoietic development, they are not involved in stromal cell-mediated
hemopoiesis (123).

This directly questions a long-held assumption of hemopoiesis

researchers.
Very little has been done to address the production of hemopoietic growth factors
in normal marrow, even though the continual production of blood cells occurring there
would suggest the presence of such growth factors. Although methods such as in situ
hybridization and immunocytochemistry would be useful in addressing which cytokines
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are produced in the marrow and by what cells, this approach is technically difficult due
to the necessity of sectioning through bone and the requirement for electron microscopy
to see thin reticular cell processes (156, 157). Recently, an ELispot assay was used to
count the number of IL-6 secreting cells in the marrow (158). However, the exact cells
producing the IL-6 were not identified in that study, rather, they were negatively selected
by FACS. Cytokine production within the marrow is, therefore, a largely unexplored
avenue of research.
Three cytokines appear to be produced solely by stromal cells in primary
LTBMC-B: IL-7, kit ligand, and M-CSF (121). Two of these, IL-7 and kit ligand,
mediate effects directly on B cell precursors (34,35,38,39). IL-7 is a cytokine with a
central role in development of both B and T lymphocytes.

IL-7 was initially

characterized and cloned from a transformed stromal cell line and appears to be very
important to the production of lymphocytes in culture (3,34,35,39,64,159).
Administration of IL-7 to lymphopenic mice results in a more rapid recovery of
lymphocytes, supporting a role for this cytokine in lymphopoiesis in vivo (160).
Additional evidence for this view is that treatment of animals with antibody that
neutralizes IL-7 results in loss of lymphocytes from the marrow (161). This loss occurs
at the stage of lymphoid development in vivo equivalent with the cells which respond to
IL-7 in vitro. This evidence suggests that IL-7 is important for lymphoid development
in the marrow but the specific cells producing IL-7 in the marrow have not been
identified.
Kit ligand (also called Stem Cell Factor [SCF], Mast Cell Growth Factor [MGF],
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or Steel Factor [SlF]) is a recently identified cytokine with broad effects, influencing
hemopoiesis, melanogenesis, and gametogenesis (47-58).

Kit ligand affects many

hemopoietic cell types, often acting in synergy with other growth factors (38,39,52). In
particular, kit ligand appears to amplify the proliferation of B cell precursors responding
to IL-7 (38,39). Administration of an antibody that inhibits the action of kit ligand leads
to a dramatic decrease in most hemopoietic lineages in the marrow (162). However,
there is a pronounced increase in lymphoid cells, even though kit ligand does appear to
affect their development. Kit ligand is produced by cultured stromal cell lines as well
as cells in primary culture (38,39,121). Again, despite strong suggestive evidence for
kit ligand production in the marrow, no one has identified the cells producing it in vivo.
M-CSF production is common among cultured stromal cell lines; in fact, M-CSF
is produced constitutively by several different adherent cell types (3,64, 121). Based on
the presence of M-CSF in stromal cell lines, it has been suggested that M-CSF is
important in in vivo hemopoiesis, possibly to maintain resident macrophages in the
marrow (122). The osteopetrotic mutant mouse is unable to produce M-CSF, leading to
a variety of deficits in the monocyte/macrophage lineage of cells (163). However, the
anemia of the animals is attributed to decreased marrow volume rather than defective
blood cell formation, again with the exception of monocytes/macrophages (164). The
expression of M-CSF in a variety of adherent cell types raises the possibility that its
expression is an artifact of tissue culture conditions. For this reason, it would be useful
to determine if M-CSF is expressed by uncultured stromal cells to gain a better
understanding of stromal cell activity in vivo.
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IV. Summary

In summary, the exact lineage derivation, location, function, and extent of
heterogeneity of the stromal cell's in vivo counterpart remain largely unknown. Stromal
cell lines are quite heterogeneous in cell surface phenotype, growth factor production,
adhesion mechanisms used, and capacity to support hemopoietic development.
Therefore, it is unlikely that any individual stromal cell line accurately reflects the
activity of in vivo stromal cells. The phenotypic heterogeneity of stromal cell lines
makes it difficult to assign them to any of the non-hemopoietic cell types known to be
present in the marrow. Such heterogeneity might reflect heterogeneity in the initial
population or phenotypic changes in a highly plastic cell type due to culture adaptation
of the transformation process itself. It is also possible that stromal cells in primary
cultures represent only a subset of those present in vivo. Stromal cell lines have been
found to make many growth factors, however, the factors that are truly important in the
normal regulation of hematopoiesis are unknown.
To date, stromal cells have principally been used as in vitro tools in the study of
blood cell development. Very little certain knowledge about the nature of stromal cells
themselves and their responses to physiologic stimuli has been forthcoming.

The

dynamic nature of hemopoiesis and the strong evidence implicating stromal cells in its
regulation would seem to make it imperative to understand stromal cells in order to grasp
the whole hierarchy of blood cell regulation. As yet there is no way to isolate stromal
cells for study directly from the marrow, isolation protocols requiring intervening
culture, again leading to the issue of culture adaptation. As well, in vitro studies suggest
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that particular stages of hemopoiesis require stromal cell contact; whereas, others can
develop in the presence of growth factors alone.

Whether such contact between

particular developmental steps and stromal cells occurs in vivo remains unaddressed.

V, Objectives
To paraphrase Tavassoli, 'Hematopoiesis occurs in the bone marrow and not in
plastic dishes' (165). In order to gain insight into the normal function of stromal cells
it will be necessary to study normal stromal cells. No matter how useful stromal cell
lines are in studying certain aspects of hematopoiesis they have not informed us of the
lineage derivation, normal growth factor production, and location of stromal cells in vivo.

Isolation of fresh stromal cells and analysis of their growth factor production,
therefore, are important ways to gain an understanding of hematopoietic regulation.
This dissertation aims to examine stromal cells; first, by enriching them directly
from bone marrow cell suspensions without intervening culture and second,
following isolation, their expression of two lymphopoietic cytokines, IL-7 and kit
ligand, will be examined.

Successful completion of this research would allow

definition and study of stromal cell phenotype and function without the complication of

in vitro culture. This will tell us if IL-7 and kit ligand are actually produced by these
cells in the marrow. Since M-CSF is produced by all stromal cell lines so far examined
I feel that it will be useful to test for production of this growth factor by
immunocytochemistry as well.
Experiments such as this are an important first step in the study of stromal cells

in situ. Study of fresh stromal cells is important in order to comprehend all aspects of
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normal hematopoietic regulation. While in vitro techniques and cell lines have been very
valuable in the study of blood cell production they can only form a part of the entire
picture. The results presented here describe attempts to enrich stromal cells directly
from fresh marrow, develop ways to identify stromal cells when freshly isolated, and
analyze their production of selected cytokines. These are all novel additions to the field
of lymphopoiesis and open new avenues of investigation to other researchers.

Once

normal stromal cells are available it may be possible to develop new and more specific
ways to identify them, particularly with monoclonal antibody reagents. The study of
defects in the hematopoietic microenvironment will be aided by having access to the
aberrant cell types. The mechanisms by which stromal cells sense and respond to their
environment and their ensuing effects on hematopoiesis can begin to be studied. These
and other areas of research will benefit from this project.
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Chapter II
ENRICHMENT OF PRIMARY LYMPHOCYTE-SUPPORTING STROMAL CELLS
AND CHARACTERIZATION OF ASSOCIATED B LYMPHOCYTE
PROGENITORS
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ABSTRACT

Studies of Whitlock/Witte long term bone marrow cultures have revealed the
necessity of two cell types for B-lymphopoiesis, a stem cell and the stromal cell. While
a number of stromal cell lines exist they have been found to be heterogeneous with
respect to cell surface marker expression and growth factor production. Separation and
analysis of fresh bone marrow stromal cells is, therefore, necessary to understand the
regulation of lymphopoiesis in vivo.

Here I report the early stages of such studies,

demonstrating that stromal cells, as assessed by morphology and alkaline phosphatase
reactivity after short term culture, are enriched in cellular aggregates that can be
separated from bone marrow suspensions. Stromal cells are present in aggregates at a
frequency of one per thousand cells whereas marrow from which the aggregates have
been removed contains only one stromal cell per fifty-thousand cells. These aggregates
are able to form Whitlock cultures from greatly reduced numbers of initiating cells,
indicating that they contain culturable B lineage precursors as well as stromal cells
capable of supporting B-lymphopoiesis. The aggregates appear to be naturally-formed
and provide a means to examine native B-cell precursor-stromal cell contacts. Little
evidence was found for sequestering of late stage B cell precursors within the aggregates.
TdT+ cells, on the other hand, are approximately three times more frequent in bone
marrow aggregates, suggesting close contact between very early B-cell progenitors and
stromal cells within the aggregates.

The finding that stromal cells are enriched in

cellular aggregates is an important first step in the ultimate isolation of these cells from
marrow suspensions, which is vital to understanding stromal cell function in. vivo.
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INTRODUCTION

Regulation of B-lymphocyte development has important ramifications for
understanding the basic biological events that initiate cell differentiation and how these
events are deranged in disease states such as leukemia, hemopoietic dysfunction, and
autoimmunity. As in the myeloid lineages, soluble factors have been identified that
appear to induce primarily B-progenitor cell proliferation and differentiation in the
marrow. These include an early differentiation factor, which can induce expression of
the B220 antigen and cytoplasmicµ H chain (143,151), and interleukin 7 (159), which
promotes pre B-cell growth. The myeloid CSFs (M-, G-, and GM-), the B-lineage
factors, and a lympho-hemopoietic factor [c-kit ligand] can be produced in vitro by a type
of bone marrow adherent cell termed a "stromal cell" (15,38,143,159,166). Specifically,
the term "stromal" has been used to describe a morphologically distinct group of very
large, highly spread adherent cells present in Whitlock and Dexter long term bone
marrow cultures (110,111).
In addition to growth factor production, a population of cultured stromal cells clearly
binds early B-lymphocytes in tight clusters on the surface and beneath the flattened
stromal membrane (167). Actual contact with stromal cells seems necessary in the early
phases of B-cell differentiation (33, 112). This cellular adhesion is mediated in part
through the VCAMl molecule, expressed on stromal cells, and the VLA-4 molecule
present on the progenitor cell surface (116). Therefore, at least in culture, bone marrow
stromal cells appear to provide key regulatory influences necessary for B-cell
development.
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The primary goal was to isolate stromal cells from fresh bone marrow in order to
examine their normal production of hemopoietic growth factors. As an initial approach
based in part on the work of Crocker and Gordon (144), it was found that the highest
frequency of culturable stromal cells in a mouse bone marrow suspension are found
enmeshed in small, cellular aggregates. Isolated aggregates are an enriched source of
fresh stromal cells as well as very immature B-lineage cells.
MATERIAl.S AND METHODS
Animals.

4 to 8 week old female BALB/c mice were purchased from Harlan

Laboratories (Indianapolis, IN) and housed at the Animal Research Facility at Loyola
University.
Cell Preparation and Long Tenn Bone Marrow Culture. Bone marrow cells were
prepared and cultured according to Whitlock et al. (105). Briefly, mice were sacrificed
by cervical dislocation and the femurs removed. Marrow was flushed from the femurs
with cold RPMI 1640 medium supplemented with 10% fetal bovine serum by inserting
a 25 gauge needle attached to a 3 ml syringe. This cell suspension was then centrifuged
at lOOOrpm for 10 minutes and the cells resuspended by pipeting 10 to 15 times through
a 5 or 10 ml glass serological pipet. Cells were resuspended at a density of 1 x 1()6 cells
per ml and plated in 60mm tissue culture dishes, 5ml per dish. Medium used for long
term cultures was RPMI 1640 supplemented with 5% selected FBS (Hyclone, Logan UT,
Lots 1111985 and 1111638), 2mM L-glutamine, 5 x 10-5 M 2-mercaptoethanol, 50 U/ml
penicillin, and 50 µg/ml streptomycin.
Isolation of Aggregates. We modified procedures previously reported for isolation of
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cell clusters from bone marrow and thymus, principally those of Crocker and Gordon
(144) and Wekerle and Ketelson (168), respectively.

After centrifugation the bone

marrow cells were resuspended at three femur equivalents per ml and vigorously pipetted
through a 5 or 10 ml pipet. 1 ml of this suspension was carefully layered over 3 ml of
cold FBS in a 5 ml tube. Aggregates were allowed to settle for 15 minutes by placing
the tube on ice in a vertical position. After 15 minutes the following fractions were
collected with a pasteur pipet: the uppermost 1 ml, which will be referred to as
deaggregated marrow; the middle 2 ml, which contained small aggregates and single
cells; and the lowermost 1 ml, which contained aggregates estimated to be 20 to 500 cells
per aggregate.
Collagenase Digestion.

Collagenase grade CLS 3 lot # FOD 671 (Worthington,

Freehold, NJ) or Collagenase A (Boehringer Mannheim, Indianapolis, IN) was used to
digest aggregates into single cells. Collagenase was used because it is rarely a pure
preparation and contains low levels of other lytic enzymes that are useful for digesting
the complex matrix of tissues. These activities can have adverse effects on cell surface
antigens, however, and it was necessary to screen several lots before an appropriate batch
was found. Collagenase FOD 671 was selected from 11 lots of collagenase by screening
for effectiveness of aggregate dispersion and for low tryptic activity by monitoring effects
on staining with mAb 14.8 by FACS. The neutral protease dispase was also tested but
proved to be particularly damaging to cell surface antigens; as little as 0.5U/ml was
found to completely remove the B220 antigen from our cell populations. Digestion
conditions used were 1 x 107 cells per ml in 0.2 % collagenase in RPMI 1640

+

10%
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FBS for 90 minutes at 37°C and 5 % C02 • Cells were passed through a 25 gauge needle
three times during this digestion in order to break up cell clumps. After digestion, cells
were washed in cold RPMI

+

10 % FCS two times before subsequent manipulations.

The percentage of cells in aggregates was calculated as the number of cells in
aggregates divided by the number of marrow cells before aggregate isolation and
collagenase treatment. This estimate is likely an underestimation of the proportion of
cells present in aggregates since we see cell loss during collagenase treatment. I have
summarized some initial experiments in working out collagenase digestion conditions to
explain how I arrived at this calculation. I have given the cell number per femur before
and after collagenase treatment, the number of cells in aggregates after collagenase
treament, and an estimate of the fraction of marrow cells in aggregates based on both
unfractioned marrow counts (fable 2). In every case the use of collagenase-treated
marrow in this calculation increases the estimate, sometimes by nearly 2-fold. Although
it is likely that cells are also lost from the aggregates it is impossible to estimate this
loss. If one calculated the percent of marrow in aggregates using collagenase treated
marrow one must assume that there is equivalent cell loss from each group. One is then
also using an estimate of the cellularity of marrow that is decreased. I feel that the most
accurate way to estimate the percent of cells in marrow is to use the most accurate count
of total marrow cells, i.e. untreated marrow, and accept that it is probably an
underestimate because of cell loss from the aggregates. Since cell loss can vary from
day to day, this allows a more stable comparison of aggregates from experiment to
experiment, and to the use of other batches of collagenase as it becomes necessary.

Table 2.--Estimating the Fraction of Marrow Cells in Aggregates
Experiment

Untreated•

Collagenase
Treated•

Aggregates•

Aggregates/
Untreatedb,c

Aggregates/
Collagenase
Treatedd

1.

9.9

7.6

0.66

0.048

0.087

2.

10.8

8.6

0.58

0.053

0.067

3.

10.1

6.0

0.26

0.026

0.043

4.

20.0

10.9

0.99

0.047

0.086

5.

12.7

12.4

0.58

0.045

0.046

6.

10.4

5.9

0.42

0.040

0.075

7.

8.9

6.9

0.95

0.106

0.138

8.

9.9

6.4

0.10

0.099

0.154

9.

7.8

6.0

0.29

0.037

0.049

• X 106 per femur.

b

Calculated as the number of cells in aggregates divided by the number of cells in treated marrow.

c Average value 0.056, within normal range of 0.081 + 0.025.

d

Calculated as the number of cells in aggregates divided by

the number of cells in unfractioned, collagenase treated marrow.
w

....:i
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Determination of Stromal Cell Frequency.

Cells were counted after collagenase

treatment, plated into 60mm tissue culture dishes, and allowed to adhere for 48 hours.
48 hours was previously determined to be sufficient for stromal cells to attach and
spread, and thus display their characteristic morphology in culture. Medium used was
identical to LTBMC-B medium except were icreased serum concentrations are noted.
In some experiments plates were precoated with 20µg/ml fibronectin (Biomedical
Technologies, Stoughton, MA), 20µg/ml laminin (Biomedical Technologies), or 20µg/ml
of Pronectin F( Protein Polymer Technologies, San Diego, CA). Also, macrophages and
monocytes from the marrow begin to actively proliferate in culture at 48 hours, so this
time point prevents excess macrophage proliferation from complicating stromal cell
scoring (personal observations). After 48 hours the medium was removed and plates
were washed 3 times with cold PBS. Cells were then fixed in methanol and stained with
Jenner/Geimsa or fixed in citrate buffered acetone and stained for alkaline phosphatase
activity.

The entire area of each plate was then examined using a phase contrast

microscope. Stromal cell frequency was estimated as the ratio of stromal cells per plate
to the total number of cells originally plated. Statistical analysis was by t-test.

Flow Cytometry. After collagenase digestion, I x 106 cells of each group were stained
with the primary antibody for 20 minutes in 50 ul of Hanks Balanced Salt Solution with
O.I % BSA. Primary antibodies were Ml/9 (anti-T200, Boehringer Mannheim); I4.8
(anti-B220, ATCC); BPI (gift of Dr. Max Cooper, Birmingham, AL). Cells were then
washed and stained with the appropriate secondary F(ab)'2 antibody for 20 minutes: for
BPI this was FITC-labelled goat-anti-mouse IgG (Fe specific) (Jackson Labs, West
Grove, PA) and for all others was FITC-labelled mouse-anti-rat lg (heavy and light
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chains) (Jackson Labs).

The cells were then washed and 10,000 viable cells were

analyzed by a Becton Dickinson F ACStar plus.

Results are shown with log10

fluorescence intensity on the horizontal axis and relative cell number on the vertical.
Immunoperoxidase Staining. Cytocentrifuge preparations were fixed for 15 minutes
in ice cold 95% ethanol with 5% acetic acid. Slides were then washed 3 times in PBS.
Endogenous peroxidase activity was blocked with 0.3% H20 2 in methanol and the slides
were again washed 3 times in PBS. At this point the slides were incubated with 10%
PCS and then stained with M/K2 for 60 minutes. MK/2 (anti-VCAMl) was a gift of Dr.
Paul Kincade, Oklahoma City, OK. Slides were washed 3 times in PBS and stained with
biotinylated rabbit-anti-rat lg (Vector, Burlingame, CA). After 3 more PBS washes
slides were stained with the Vector ABC Elite kit (Vector).

Horseradish peroxidase

enzyme activity was detected by immersing the slides in 0.67mg/ml diaminobenzidene
for 15 minutes. Slides were counter stained in hematoxylin, washed, dried, and observed
by bright field microscopy.
Immunofluorescence Microscopy. B/pre-B differential immunofluorescence (32) was
determined by staining cells in suspension with FITC conjugated goat-anti-mouse µ
(Jackson Labs).

10' cells were cytocentrifuged onto slides, fixed in ice cold

ethanol/acetic acid, and stained with TRITC conjugated goat-anti-mouse µ (Jackson
Labs). Slides were then scored for cµ+ pre-B cells (red fluorescence) and sµ+ B cells
(green and red fluorescence) using a fluorescence photomicroscope. At least 250 cells
were scored per slide. Results are presented as means of three slides

± SD. Detection

of terminal deoxynucleotidyl transferase (TdT) in the nucleus was done by using kit no.
1480 (Supertechs, Bethesda, MD). Cytocentrifuge spots were prepared with 10' cells.
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The cells were fixed with methanol and stained with rabbit-anti-mouse TdT followed by
goat-anti-rabbit lg FITC. At least 600 cells were scored on each slide.
CFU ~ys. Following collagenase digestion, 1<>5 cells of each group were plated in
McCoy's modified Sa medium supplemented as described previously (34). Recombinant
IL-7 (Biosource, Westlake Village, CA) was used at 500U/ml (34). Cells were plated
in 1 ml volume in 35 x 15 mm Lux Contuor (Nunc, Naperville, IL) dishes. Plates were
incubated in 7 .5 % COi in air at 37°C for 6 days. At that time colonies > 20 cells were
scored using a dissecting microscope. The data are reported as mean + S.D. of at least
three plates per group.
H Thymicline Proliferation ~Y. Bone marrow populations were plated at various

3

concentrations in 96 well plates and pulsed with 1 µCi/well of 3H TdR for 18 hours.
Cells from each well were then harvested with a PhD cell harvester and counted in a {3scintillation counter. Results are mean + SD of three or four wells.
Cell Cycle Analysis. 2"-3 x 106 cells of each bone marrow population were fixed in 70%
ethanol at 4°C overnight. Cells were then incubated briefly with RNase, washed, stained
with propidium iodide, and analyzed by a FACStar Plus (166). Data presented are the
total percentage of cells in S

+ G2M of each population.

RESULTS

Strom.al cells are enriched by iso'lating cell aggregates.
Two days after Whitlock cultures were initiated, most of the adherent cells were
observed in discrete foci on the tissue culture dish (Fig. IA), appearing as if they were
growing out from cell clusters or aggregates present in the marrow suspension. This
observation led to speculation that most of the stromal cells in an adherent layer of a
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Whitlock culture might be obtained merely by separating aggregates from whole marrow
suspensions. As a means of isolating cell aggregates, procedures were adapted from
Wekerle and Ketelson for enrichment thymic nurse cells (168) and Crocker and Gordon
(144) for enrichment bone marrow resident macrophages. Briefly, cellular aggregates
were isolated by unit gravity sedimentation over a fetal calf serum layer (see Methods).
Collagenase dispersed aggregates contained an average of 8.1

+ 2.5 x 1<>5 cells per

femur or about 8% of total marrow nucleated cells. This average was derived from 16
independent experiments and is representative of every experiment performed on
aggregate isolation.
As evidence that stromal cells were present in aggregates, Figure 1 shows two
markers that have been reported on stromal cells in vivo and in vitro.

The first is

alkaline phosphatase activity (67,167,169) (Fig. IA) and the second is the VCAMl
antigen detected by rat mAb M/K2 (113, 116) (Fig. lB). A reticular staining pattern has
been reported for both of these proteins in vivo (67,113) and this pattern was also seen
in the aggregates. Staining was generally confined to aggregates but not every aggregate
showed reactivity for alkaline phosphatase or VCAMl. The similarity in staining of
marrow sections and aggregates suggests that a native cell architecture from intact
marrow may be somewhat preserved during preparation of cell aggregates.
To demonstrate that stromal cells were enriched in the aggregates, short-term (48
hour) culture assay was devised that enabled culturable stromal cells to be counted before
significant proliferation of adherent cells occurred. The number of culturable stromal
cells present in bone marrow fractions were quantitated based on two previously
described characteristics of adherent stromal cells in long-term culture: distinctive
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Figure 1. Localization of alkaline phosphatase (A) and VCAMl (B) in aggregates. A)
Aggregate stained for alkaline phosphatase reactivity (blue stain) with safranin
background. B) Immunoperoxidase stain for M/K2 (brown areas positive). C) Negative
control for M/K2 stain showing background peroxidase activity.
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morphology (110,111) and alkaline phosphatase activity (67, 167,169) (Table 3). Stromal
cells were judged as large, highly spread cells with abundant pseudopodia, a relatively
clear cytoplasm, and distinctive oval nuclei with prominent nucleoli. Stromal cells were
distinguished from macrophages, the predominant adherent cell type, because the latter
were smaller, more fusiform, and had a granular cytoplasm.

All cells with stromal

morphology retianed their alkaline phosphatase reactivity and VCAMl expression
through 48 hours culture (data not shown). A notable result of these experiments was
the extremely low frequency of readily culturable stromal cells in whole marrow

(-0.04% of total cells). Aggregates were 2.5 to 3 fold enriched in readily culturable
stromal cells, which were present at a frequency of 0.1 %. Deaggregated marrow, on
the other hand, was substantially depleted of stromal cells. Stromal cells were found to
be only one in about fifty-thousand cells in deaggregated marrow, or fifty times less
frequent than in aggregates. Therefore most of the recoverable stromal cells found in
marrow are present in aggregates. Comparison with the number of stromal cells found
in untreated marrow indicated that some of the stromal cells were lost during our
isolation procedure (see DISCUSSION).
To ensure that our short-term culture assay was optimal for stromal cell detection
experiments were performed to test the effects of culture conditions on stromal cell
plating. In these experiments collagenase treated unfractioned marrow was used to assess
stromal cell plating efficiency. Since the primarily interest was in the stromal cells that
support B lymphopoiesis, the conditions of LTBMC-B culture were used. Initially, the
serum lot used was altered, reasoning that the serum dependence of LTBMC-B cultures
might be due in part to effects on stromal cells (Fig. 2A). Although some variability in

Table 3.--Frequency of Culturable Stromal Cells in Aggregates•
Untreated

Unfractionedb

Deaggregatedb

Aggregatesb

No. of Cells Plated

1x106

1x106

5

No. of Stromal Cells

331 + 152

470 + 177

74 ± 13

1011

Frequency
Stromal Cells

3.3

1.5 X 10-5

1.1

x

10-3

0.9

x

106

Experiment 1c

of

x

104

4.7

x 104

x 106

0.9 x 106

± 177

Experiment 2

x

106

No. of Cells Plated

1x106

1x106

5

No. of Stromal Cells

407 + 77

302 ± 16

88 ± 15

976 ± 140

Frequency
Stromal Cells

4.07

1.8 X 10-5

1.1

of

x 104

3.02

x 104

x 10-3

• Stromal cells were allowed to adhere in 60mm plates for 48 hours and nonadherent cells were washed off with PBS. Adherent cells
were then fixed and stained with Jenner/Giemsa (Expt. 1) or for alkaline phosphatase (Expt. 2) directly on the plate. Stromal cells
were then scored by their morphology using a phase contrast microscope. b Treated with collagenase.

c

Expt. 1 is representative

of two studies.
~
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stromal cell recovery was evident among the serum lots, those that supported
lymphopoiesis in culture (lots # 985, 1087, 2045, and 2034) were generally best at
stromal cell recovery. There was no statistical difference among these lots. Increasing
the concentration of serum in the medium used in the plating assay, using serum lot
2034, did not increase stromal cell plating efficiency (Fig. 2B). The possibility that
factors secreted by stromal cells or hemopoietic cells in LTBMC-B might affect stromal
cells was also considered. Addition of LTBMC-B conditioned medium did not influence
stromal cell plating in the 48 hour culture assay (Fig. 3A). Certain cell types adhere
better to cultureware that has been coated with extracellular matrix components.
Therefore, fibronectin, laminin, and a synthetic polymer containing multiple repeats of
the RGD binding sequence from fibronectin (Pronectin)(Fig. 3B & C) were tested.
Fibronectin, although it increased stromal cell recovery occassionally, did not
consistently affect stromal cell plating, nor did the conbination of fibronectin with
LTBMC-B conditioned medium. Laminin, on the other hand, inhibited stromal cell
recovery. Certain cells, notably endothelial cells, require a minimal initial cell density
to grow in culture, an effect known as cooperativity (170). Since it has been suggested
that stromal cells are endothelial in origin (96) it is possible that cell density might affect
stromal cell plating efficiency. The number of stromal cells varies linearly with the
number of plated bone marrow cells over a 100-fold range of input cells (Fig. 4), arguing
against cooperativity among stromal cells.

The previous experiments all used

unfractioned marrow as a source of stromal cells. However, it is possible that aggregate
stromal cells are a distinctive population, therefore we tested the various conditions on
stromal cells derived from collagenase dispersed aggregates (Fig. 5). Again, no
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Figure 2. Effects of serum on stromal cell plating. A) Effects of different serum lots.
B) Effects of increasing serum concentration. Unfractioned collagenase treated marrow
was used as a source of stromal cells, 3.4 X 105 cells per plate.
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Figure 3. Effects of medium additions or extracellualr matrix components on stromal
cell plating. A) Effects of conditioned media from 3 or 8 week old LTBMC-B cultures.
B) Effects of extracellular matrix components fibronectin (FN) and laminin (LM). C)
Effects of fibronectin or pronectin (ProN) alone or in combination with 10 % conditioned
medium from LTBMC-B. Unfractioned collgenase treated marrow was used as a source
of stromal cells, 3.4 X 1<>5 cells per plate.
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Figure 4. Effects of cell density on stromal cell plating.
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Figure 5. Effects of fibronectin (FN), LTBMC-B conditioned medium (CM), pronectin
(ProN), or FN plus CM on plating of stromal cells from collagenase dispersed
aggregates, 1. 7 X 105 cells per plate.
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differences were seen among stromal cell plating in each of the tested conditions.
Therefore, none of the relatively straightforward tactics commonly used to improve cell
plating efficiency in other systems increase the plating of stromal cells. Importantly,
these results do not mean that this culture assay detects all stromal cells present, these
results to mean stromal cells are not readily aided in plating.
Since the primary interest of the laboratory is lymphopoiesis, it was important to
determine if stromal cells derived from aggregates were able to support lymphocyte
growth in culture. Whole marrow prepared as in a standard Whitlock culture (105) is
plated at a density of lx1<>6 cells/ml or 5xl06 cells/60mm dish. At this concentration
cultures typically developed a nearly confluent adherent layer between 14 and 21 days
after initiation, and foci of proliferating lymphocytes appeared by day 21 (Fig. 6A-C).
Cultures of aggregates followed an identical pattern of culture development, forming a
confluent adherent layer around day 17. Lymphocyte foci were visible in aggregate
cultures around day 21 (Fig. 6D-F). Notably, collagenase-dispersed aggregates were
capable of establishing a Whitlock culture from an initiating cell density of 2-4x10S
cells/ml or 1-2xl06 cells/60mm dish, as few as one-fifth the number of whole marrow
cells needed to initiate culture. However, cultures of deaggregated marrow initiated at
5xl06 cells/60mm dish proved unable to form Whitlock cultures (Fig. 6G-I).
Deaggregated marrow cultures developed a sparse adherent layer and rarely gave rise to
lymphocytes even when maintained for up to 3 months. This result would be expected
given the data in Table 1 showing the vast depletion of stromal cells in deaggregated
marrow. Thus, the bone marrow aggregates contained all of the elements necessary to
form a Whitlock culture, and since five-fold fewer cells were capable of forming a
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Figure 6. Comparison of Whitlock cultures initiated from marrow fractions. Whitlock
culture initiated with whole marrow at: A) 2 days, B) 17 days, and C) 21 days. Cultures
initiated with aggregates at: D) 2 days, E) 17 days, and F) 21 days. Cultures initiated
with deaggregated marrow at: G) 2 days, H) 17 days, and I) 21 days.
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sufficient adherent layer, aggregates appeared to be an enriched source of lymphocytesupporting stromal cells.

Phenotypic analysis of hemopoietic cells present in aggregates.

Because long term

lymphopoiesis forms from aggregates, progenitor cells as well as the appropriate stromal
cells must be present.

Stromal cell-progenitor cell contact is required for in vitro

lymphopoiesis (112) and similar contacts have been reported in vivo (68). However, the
precise stages of B-lymphocyte differentiation that are sequestered by stromal cells
remains unknown. The apparently naturally-formed cell aggregates would seem to offer
an avenue toward addressing this question.

Thus, aggregates were dispersed using

collagenase and the cells subjected to various phenotypic analyses, comparing these with
unfractionated and deaggregated marrow suspensions.
Overall hemopoietic content of aggregates was assessed by FACS analysis using
mAb Ml/9 against mouse T200 (CD45) (17l)(Fig. 7A) and by morphology after
Jenner/Giemsa staining (Table 4).

The frequency of T200+ cells and their mean

fluorescence intensity were similar in unfractioned, deaggregated, and dispersed
aggregate marrow suspensions, indicating that the populations were alike in their total
hemopoietic content.

The T200 antigen seemed to be slightly degraded by this

collagenase lot; however, the curves for unfractioned collagenase treated marrow,
deaggregated marrow, and aggregates were all overlapping. By differential counting,
little difference overall was seen between unfractioned marrow and dispersed aggregates,
with the exception of eosinophils.
Because morphology alone cannot discriminate early B cell stages, a panel of well
described B lineage markers was used to assess whether early B cells were more frequent
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Figure 7. F ACS profiles of bone marrow populations. In all figures A refers to untreated
marrow, B to unfractioned collagenase treated marrow, C to deaggregated marrow, D
to collagenase dispersed aggregates, and E to untreated marrow stained with only the
secondary antibody reagent. A) T200 staining. B) B220 staining. C) BPl staining. Note
that panel C compares the fluorescence intensity of untreated marrow (shaded histogram)
to that of dispersed aggregates (unshaded histogram). Histograms in panel C are gated
on cells with forward and side scatter channels typical for lymphoid cells. All profiles
represent 2 to 6 experiments for each antibody. Relative cell number is on the vertical
axis and increasing fluorescence intensity is on the horizontal axis.
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Table 4.--Morphology of Cells in Bone Marrow Populations•

Untreated

Deaggregatedb

Lymphoid

22.3

29.6

±

Granulocytic

39.0

48.6

Erythroid

34.6

18.6

Eosinophilic

2.8

3.3

Aggregatesh
24.1

±

+ 8.4

34.4

+ 4.7

+ 3.6

34.8

±

+

3.0C

1.7

6.1

±

2.0

7.6

0.9

• Cytocentrifuge preparations of each of the respective populations were stained with
Jenner/Giemsa. b Dispersed with collagenase.

c

Average of three experiments

+ S.D.
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in the stromal cell containing aggregate fraction. First, the B lineage marker mAb I4.8
(anti-B220) (29) was used to determine the frequency of committed B lineage cells (Fig.
7B).

Again, no differences were seen among the groups with respect to either the

percentage of B220+ cells or their mean fluorescence intensity. Next, the mAb BPI
(I72) was used to examine the content of pre-B cells and newly formed B cells. FACS
analysis with BPI showed that there was a low level staining of all groups, which is
characteristic of this antibody (data not shown).

Aggregates, however, showed an

increase in the frequency of BP I+ cells as compared to whole marrow, suggesting an
enrichment of immature B cells in aggregates (Fig. 7C). To further define this apparent
enrichment two-color immunofluorescence microscopy for µ chain was performed to
determine the numbers of pre-B (cµ +) cells and B (sµ +) cells in each population (Table
5)(32). The collagenase treatment had no effect on the ability to detectsµ+ cells. The
data demonstrate that deaggregated marrow was virtually identical to whole marrow with
respect to its content of pre-B and B cells.

Aggregates, however, contained a

consistently higher frequency of cµ + pre-B cells and lower frequency of B cells than
whole marrow.
Hardy et al. have shown that pre-B cells prior toµ expression are responsive to
IL-7 (33). IL-7 responsiveness can be assessed in a CFU-pre-B assay as described by
Lee et al. (34). This assay was used to assess the number of clonable IL-7 responsive

cells in aggregates (Table 6).

Although the actual numbers of CFU-pre-B varied

considerably from experiment to experiment, the data within each experiment indicated
no selective enrichment or depletion of CFU-pre-B in any of the groups. It must be
noted that this assay only enumerates those cells capable of responding to IL-7 alone.

Table 5.-- Percentage of B(sµ+) and pre-B(cµ+) Cells in Bone Marrow Populations•
Unfractionedb

Untreated

Deaggregatedb

Aggregatesb

pre-B

B

pre-B

B

pre-B

B

pre-B

B

Expt. 1

14.9 +
2.3

10.9 +
3.1

16.7 +
1.7

10.0 +
1.9

16.0

16.4

23.1

7.6

Expt. 2

16.7
0.3

±

8.7
1.5

±

16.8 +
3.3

6.1
3.7

+

14.4 +
0.4

6.4
2.4

Expt. 3

14.0 +
1.4

7.4
0.8

±

14.8 +
1.3

9.9
0.7

+

11.7
0.5

±

+

10.5 +
0.9

±

3.0
1.3

±

20.7 +
1.4

7.4
1.7

±

23.4
1.7

•Band pre-B cell numbers were determined by staining cells in suspension with FITC conjugated anti-mouseµ to determinesµ+
cells. These cells were then spun onto cytocentrifuge spots, fixed in cold ethanol/acetic acid, and stained with TRITC conjugated
anti-mouseµ to determine cµ+ cells. A minmum of 250 cells per slide were scored on a epifluorescence microscope. b Treated
with collagenase.

c

Average of three slides + S.D.

~

Table 6.--CFU-pre-B (IL-7) in Bone Marrow Populations•
Untreated

± 3.3

Unfractionedb

Deaggregatedb

Aggregatesb

+ 9.3

99.3 + 19.0

29.7

± 5.8

Experiment 1.

64.3

Experiment 2.

59.0 + 9.2

72.8 + 6.1

76.7 + 26.6

64.8

± 6.9

Experiment 3.

31.5 + 26.1

37.8 + 1.3

21.0+4.1

28.3

± 2.5

55.5

• 1<>5 cells of each bone marrow population were plated in an IL-7 colony assay as described in Materials and Methods. Colonies

> 20 cells were counted after 6 days incubation. Results are presented as the mean + S.D. of 4 individual plates. b Treated with
collagenase.

g:
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Earlier B cell types also require stromal cell contact for proliferation (33) and are
presumably not detected in the semi-solid agar assay.
The enzyme terminal deoxynucleotidyl transferase (TdT) may be the first
identifiable marker of early B lineage cells and represents a means to measure early B
lineage precursors that may not be responsive in the IL-7 colony assay. Table 7 shows
that there was a consistent increase in the frequency of TdT + cells in the aggregates and
a consistent decrease in these cells in deaggregated marrow. This finding suggests that
aggregates are enriched for very early B lineage cells that may be in close association
with stromal cells in vivo.
Given that the earliest identifiable B cell precursors are more mitotically active
than later stage cells (173, 174) the proliferative activity of aggregate cells was examined.
Table 8 shows that equivalent numbers of aggregate cells incorporated 2 to 4 times as
much 3H TdR as whole marrow or deaggregated marrow in an 18 hour pulse. Since the
stromal cells that presumably provide signals for cell proliferation have been removed
from deaggregated marrow, the possibility existed that the cells in that fraction exited the
cell cycle and incorporated less radioactivity. To more definitively explore differences
in the proliferative activity of aggregates from other marrow fractions, cell cycle analysis
by propidium iodide staining of nuclear DNA (Table 8)(167) was performed. The results
show a modest but consistent increase in the frequency of cells in S+G2M of the cell
cycle in aggregates versus deaggregated marrow.
CONCLUSIONS
This work led to the following conclusions:

1) stromal cells are enriched in

cellular aggregates that can be separated from marrow cell suspensions, 2) stromal cells
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that can be identified in short-term culture constitute a very minor proportion of total
marrow cells, 3) cellular aggregates are sufficient to form LTBMC-B cultures and must,
therefore, contain both stromal cells and very primitive hemopoietic precursors, 4) short
term culture of stromal cells is serum sensitive but relatively independent of serum
concentration, extracellular matrix components, or initial plating density, 5) aggregates
may preferentially include cells from the subendosteal marrow, 6) aggregates appear to
represent areas of native marrow architecture, 7) there is little evidence for sequestering
of middle and late stage B cell progenitors in the aggregates, and 8) aggregates are
enriched in TdT+ early B cells.

Table 7.--Frequency of TdT+ Cells in Bone Marrow Populations•
Untreated

Unfractionedb

Deaggregatedb

Aggregatesb

Experiment 1.

1.5

1.4

N.D.c

3.9

Experiment 2.

1.3

1.4

0.8

3.1

Experiment 3.

N.D.

1.6

0.6

4.0

• TdT positive cells were determined by indirect immunofluorescence on fixed cytocentrifuge spots. A minimum of 600 cells were
scored per slide. b Treated with collagenase.

c

Not Done.

$

Table 8.--Proliferative Activity of Marrow Fractions
Untreated
cpm of 3H Tdr
Incorporatedb

%S

+ G2Mc

Unfractioned•

Deaggregated•

Aggregates•

Expt. 1

4411

+ 852

5275

± 2370

7911

+

Expt. 2

5980

+ 2009

3745

± 4479

3175

+ 498

Expt. 1

22.7

21.2

22.6

26.6

Expt. 2

22.0

23.8

24.1

28.0

1281

20937

± 143

19154

± 7155

•Treated with collagenase. b As determined by 18 hour pulse with 3H Tdr. c As determined by analysis of propidium iodide staining
of fixed cells on FACStar Plus.

~

71

Chapter m
ACTIVITY OF KIT LIGAND AND INTERLEUKIN-7 IN COMBINATION ON
NORMAL BONE MARROW B LINEAGE CELLS
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ABSTRACT
The production of B cells is regulated by soluble and cell contact signals presumably
provided by bone marrow stromal cells.

Among these is interleukin-7, a well

characterized proliferative stimulus for a subset of pre-B cells. Kit ligand, a stromal cell
derived cytokine with broad hematopoietic effects, has been reported to synergise with
interleukin-7 to drive the proliferation and differentiation of B220- bone marrow cells into
B220+ B cell precursors in long term culture. A subsequent report has cast doubt on this
result by showing that kit ligand and IL-7 were incapable of producingµ+ pre-B cells
after short term culture. Here, using the cell sorter to assure discrete separation of
B220+ and B220- cells followed by soft agar culture to prevent interaction with accessory
cells, I demonstrate that the combination of kit ligand and IL-7 does not stimulate the
expansion or differentiation of B220- lymphoid precursors but can act synergistically in
the clonal proliferation of B220+ cells. These experiments were begun in an attempt to
develop an assay for B220- B cell precursors which could then be applied to aggregates.
The results here confirm a role for kit ligand in B lymphopoiesis, supporting the rationale
for examining it's expression in freshly isolated stromal cells.
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INTRODUCTION

Having begun to dissect the stages of B cell development that are enriched in
aggregates, a method to determine the frequency of the earliest B cell precursors was
desirable. Such a method had not been reported, but work by McNiece and coworkers
suggested that the combination of kit ligand (KL) and IL-7 could stimulate B cell
formation from marrow that had been depleted of all identifiable committed B cells (38).
Therefore, experiments based on the results of McNiece et al. were undertaken to
develop such a quantitative assay.

As well, firm evidence for a role for KL in B

lymphopoiesis would make this an important cytokine to study in freshly enriched stromal
cells.
A number of growth factors can influence B lymphocyte development. Principal
among these is interleukin-7 (IL-7)(159). IL-7 acts as a proliferative stimulus on a subset
of pre-B cells that expressµ heavy chain in the cytoplasm (cµ). This is the basis of a
clonal soft agar culture assay that can be used to quantitate the frequency of pre-B cells
(34).

Hardy and colleagues described B22o+ cells prior to µ expression that are

dependent on both IL-7 and contact with a stromal cell line (33). As well, cµ+ pre-B
cells develop from n220- forebears in response to a factor(s) from another stromal cell
line (143).
KL is a stromal cell derived cytokine that synergizes with other cytokines to
stimulate multiple lineages of blood cells, most prominently the erythroid and myeloid
lineages (52). McNiece and coworkers reported that KL in combination with IL-7 in
liquid culture causes the proliferation and differentiation of n220- cells to become B22Q+
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cells (38). Indeed, stromal cell derived KL seems a likely candidate for promoting
differentiation of early B cells, a subset of which expresses the KL receptor (c-kit)(l62).
While it is possible that KL stimulates B220- pro-B cells to proliferate and
differentiate, it is difficult to reconcile this with previous in vivo data suggesting that B
lymphopoiesis can proceed even if c-kit is inhibited (162), and B cell development
appears normal in adult Sl!Sl' and W/W' mice (175,176). Using a short term culture
assay, Billips et al. argue against a role for KL in differentiation of B220- B cell
precursors to become cµ+ pre-B cells (39). These authors contend that the conclusions
of McNiece et al. are incorrect due to insufficient purity of the B220- cells. Yet, the
observations of Billips and colleagues are limited to the expression of µ protein;
proliferation and expression of B220 were not examined on normal marrow B cell
precursors.

What remains, then, is doubt about the role of KL in B lymphocyte

development. Here the FACS was used to obtain homogeneously pure populations of
B220+ and B220- cells from mouse bone marrow and their responses to KL, with and
without IL-7, were examined in a classical soft agar colony assay. This system prevents
any interaction with accessory cells that could influence B cell precursors and allows
clear delineation of their response to these factors.
MATERIALS AND METHODS
Cell Preparation and Flow Cytometry. A fresh marrow cell suspension was washed
once and resuspended at 2 x 107 cells per ml in Hank's balanced salt solution with 0.1 %
BSA and monoclonal antibody 14.8 (29)(anti-B220, ATCC, Rockville, MD). After 30
minutes incubation on ice the cells were washed, resuspended, and stained with FITC-
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labelled mouse-anti-rat lg (heavy and light chains, Jackson Labs, West Grove, PA).
Cells were then washed again; fluorescence positive and negative cells were sorted using
a Becton Dickinson FACStar PLUS (Mountain View, CA).
Colony Forming Unit (CFU)

A~ys.

Recombinant IL-7 (Sterling Drug, Malvern, PA)

was used at lOOOU/ml (specific activity 4. 7 x 107 U/mg) and recombinant rat KL (lot
# R500-1, Amgen, Thousand Oaks, CA) was used at lOOng/ml. These concentrations
resulted in maximal colony formation in titration experiments.
Cell Phenotyping. Colonies were removed from the soft agar cultures using a 5µ1
pipetman, being careful to remove as little agar as possible. Approximately 5 x 1()4
pooled cells were cytocentrifuged onto glass slides and stained with Jenner/Giemsa. The
content of lymphoid, myeloid, or undifferentiated cells was determined by microscopic
examination. Separate slides were stained with mAb 14.8 followed by FITC-conjugated
mouse-anti-rat lg (Jackson Labs). Other slides were fixed in ethanol/acetic acid at 4°C
and stained with TRITC-conjugated goat-anti-mouseµ (Jackson Labs). The cells were
then scored for B220+ or µ + cells using an epifluorescence microscope.
Liquid Culture of B220· Cells. B220- cells were sorted directly into 24 well plates
(Corning, Corning, NY) containing 1 ml of RPMI 1640 supplemented with 20% FCS
and growth factors as described above. The final cell concentration was 2 x lOS/ml.
Cultures were incubated at 37°C in 7.5% C02 • At 7 days 0.5 ml of medium was
replaced with fresh medium containing growth factors and any cells removed were
returned to the cultures.
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RESULTS AND DISCUSSION
To determine if KL plus IL-7 caused B220- bone marrow cells to become pre-B cells,
it was necessary to separate B220+ and B220- cells. F ACS sorting was used to do this
because it can effectively separate cells expressing low levels of a given cell surface
molecule.

This was an important consideration because the earliest B lineage cells

express low levels of B220 (33). These B220'1im cells may respond to KL plus IL-7, yet
are already committed to development within the B lineage. These would also be the
most likely contaminants of B220- cells selected by panning. To critically determine the
phenotype of cells responding to KL plus IL-7 it was important to include B22Qdim cells
in the B220+ fraction. Bone marrow was prepared and stained for B220 expression as
described. An aliquot of the stained cell suspension was set aside for use as the unsorted
marrow control. Cells were sorted according to the gates shown in Figure SA. Post-sort
analyses of the B220- and B220+ populations are given in Figure SB and C, respectively.
After sorting, cells were cultured in soft agar with IL-7, KL, KL plus IL-7, or no added
growth factors.
The results of three independent experiments are shown in Figure 9. From unsorted
marrow, IL-7 produced colonies composed ofµ+ lymphoid cells, as described previously
(34 and Table 9). KL alone resulted in variable numbers of colonies but few cells were
lymphoid (Table 9, A. Varas, unpublished observations).

The numbers of colonies

resulting from KL plus IL-7 were additive. Many colonies formed from KL plus IL-7
were larger than those formed in the presence of IL-7 alone, both in unsorted and B220+
fractions.

Cells responding to the combination of KL and IL-7 were a mixture of
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lymphoid and myeloid lineages.
As expected (34), all responsiveness to IL-7 alone was found among the B220+ cells.
In the first and third experiments, the addition of KL did not lead to increased colony
formation by B220+ marrow. In the second experiment, the addition of KL led to an
increase in colony formation (p> .005). This may reflect the variability previously noted
in the pre-B colony assay using BALB/c marrow (Chapter II). Nonetheless, IL-7, with
or without KL, stimulated colonies composed almost entirely of lymphoid cells, the
majority of which expressed µ (Table 9).
Conversely, all responsiveness to KL alone was confined to B220- marrow. In
all experiments KL plus IL-7 yielded only as many colonies as KL alone from B220marrow.

KL produced colonies composed of myeloid and undifferentiated cells,

regardless of the presence of IL-7.

Therefore, the B220- cells, without the help of

accessory cells or other factors, appear unresponsive to IL-7. The colonies in experiment
2 could not be phenotyped due to the poor colony response to KL.
The proliferation of B cell progenitors in liquid culture with IL-7, KL, or KL plus
IL-7, as described by McNiece et al. (38) was also tested. B220- marrow cells were
directly sorted into 24 well plates containing the growth factors.

Even with media

replacement at 7 days, all cultures declined and by 14 days no viable cells remained. It
is possible that the cell proliferation reported in their study was supported in part by
stromal cells present in the n220- marrow.

No adherent cells were present in my

cultures, probably because stromal cells are largely bound in cell aggregates which would
not pass through the 70µm sort nozzle (Chapter II).
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CONCLUSIONS
This work led to the conclusion that KL acts with IL-7 on cells already expressing
B220 and committed to development as B lymphocytes. The combination of KL and IL7 in culture, therefore, does not constitute an assay system for B220- pro-B lymphocytes,
as would be predicted by the data of McNiece and coworkers (38). The use of soft agar
culture prevents contact with accessory cells that could influence differentiation of
primitive B cell predecessors. As suggested by Billips et al. (39), such contacts cannot
be replaced by the addition of soluble KL.
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Figure 8. A) Fluorescence profile of normal mouse bone marrow stained for B220
expression in experiment 1. Relative cell number is on the Y axis and log fluorescence
intensity is on the X axis. Region 1 indicates sorting gates used to separate B220- cells.
Region 2 indicates the sorting gates used to separate B220+ cells. B) Post-sort analysis
of B220- cells, purity >99%. C) Post-sort analysis of B220+ cells, purity >93%. In
experiment 2 the purity of both populations was 98 %. In experiment 3 the B220+ cells
were > 93 % pure and the B220- cells > 99 % pure.
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Figure 9. Colony formation by unsorted, B220+, and B220- marrow cells in response to

KL, IL-7, or KL+IL-7. All bars represent the mean + SD of at least three plates
except

* which denotes the mean + SD of two plates.

# denotes a significant increase

in colony response (p > 0.005) over that seen with IL-7 alone.
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Table 9. --Phenotype of Cells in Colonies in Experiments 1 and 3
Percent of Total•
Cells

Condition

Lvmohoidb

Unsorted

IL-7

86; 97c

B220-

8•
'

Blastb

3

6; 0

2

72; 85

24; 13

KL+ IL-7

64; 68

23; 29

IL-7

90; 95

2·

KL+ IL-7

88; 97

4•
'

KL

B220+

Mveloidb

4•
'

'

µ+c

B220+d

86; 93

ND; 85

6·

3

ND; 4

13; 3

55; 45

ND; 61

5

8; 0

76; 93

ND; 94

3

9; 0

67; 87

ND; 99

'

KL

5; 3

77; 97

17; 0

Cf· 0

ND; 0

KL+ IL-7

4; 11

74; 79

21; 11

2·

ND; 0

'

'

6

•A minimum of 100 cells were scored per slide except where noted. B220+ with KL and B220- with IL-7 resulted in too few cells
to analyze. ND; Not Done. b Assessed by morphology after Jenner/Giemsa stain. Blasts column denotes cells with undifferentiated
morphology.

c Stained for µ immunofluorescence without distinguishing cµ from sµ cells.

d Determined by indirect

immunofluorescence staining with mAb 14.8. c Analyses of colonies from experiments 1; 3. r Only 15 cells seen on this slide.
00
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Chapter IV
NATIVE ASSOCIATIONS OF EARLY HEMOPOIETIC STEM CELLS AND
STROMAL CELLS ISOLATED IN BONE MARROW CELL AGGREGATES,
INCLUDING DEVEWPMENT OF A QUANTITATIVE ASSAY FOR 'pro-B'
CELLS
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ABSTRACT

In suspensions of murine bone marrow many stromal cells are tightly entwined with
hemopoietic cells.
marrow.

These cellular aggregations appear to exist normally within the

Previous studies documented that lymphocytes and stem cells adhered to

stromal cells via vascular cell adhesion molecule 1 (VCAMl). Injection of anti-VCAMl
antibody into mice disrupts the aggregates, demonstrating the importance of VCAMl in
the adhesion between stromal cells and hemopoietic cells in vivo. Early hemopoietic
stem cells were shown to be enriched in aggregates by using a limiting-dilution culture
assay. Myeloid progenitors responsive to WEHI-3CM in combination with kit ligand and
B22Q- B cell progenitors responsive to insulin-like growth factor- I (IGF-1) in

combination with interleukin-7 (IL-7) are not enriched. These experiments further my
characterization of the stromal cell-enriched aggregates.
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INTRODUCTION
In initial attempts to isolate stromal cells from fresh marrow, it was found that
a large portion of bone marrow stromal cells are physically entwined with hemopoietic
cells, forming cellular aggregates in marrow cell suspensions (Chapter II). Stromal cells
within these aggregates are highly reticular, as manifest by staining for two stromal cell
associated molecules, alkaline phosphatase and VCAMl (Chapter II,67,113). These
stromal cell reticular processes interdigitate with numerous hemopoietic cells in much the
same way as is seen in marrow sections (68, 113). Thus, the aggregates appear to be
naturally-formed and reflect normal cell associations in the marrow.
important for stromal cell/hemopoietic cell adhesion in vitro (113).

VCAMl is
Although it is

expressed on stromal cells within native marrow, its function is as yet untested in vivo.
The presence of VCAMl + stromal cells entwined with hemopoietic cells in aggregates
represents a unique way to examine the use of VCAMl mediated adhesion in normal
bone marrow.
Aggregates are enriched in certain early B cell precursors and are capable of
forming LTBMC-B from reduced numbers of initiating cells (Chapter II).

Because

lymphopoiesis initiates from Thyl1o stem cells (177), the latter observation suggests that
these may also be enriched within the aggregates. Sequestering of specific differentiative
steps of hemopoiesis within aggregates may imply the necessity of stromal cell contact
for that stage, enabling dissection of stromal cell dependent phases of development. In
the present studies examined the content of early hemopoietic stem cells as well as early
precursors of both the lymphoid and myeloid lineages within bone marrow cell
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aggregates.
MATERIAIB AND METHODS
Collagenase Dispersion of Aggregates. A cocktail of 0.2% collagenase (grade CLS 3
lot # FOO 671, Worthington, Freehold, NJ), 0.1 % hyaluronidase (grade HSE,
Worthington) and DNase I (Worthington) in RPMI + 10% FBS was used to digest
aggregates into single cells. Cells were digested in this cocktail for 1.5 to 2 hr at 37°C
with 70rpm agitation on an orbital shaker. After digestion, cells were washed twice in
cold RPMI 1640 with 10 % FBS before subsequent manipulations.
Anti-VCAMl Treatment In Vivo. 50µg M/K2(l13)(anti-VCAM1) in PBS was injected
i. v. into each mouse. In parallel, mice received 50µg rat IgG (Sigma, St. Louis, MO)

in PBS or PBS alone. The animals were sacrificed 15 or 30 minutes after injection, the
femurs were removed, and aggregates were isolated as described above. Aggregates
were dispersed in 0.2 % collagenase for 1.5 hr. and the viable cells counted and
compared to the number of cells present per femur in the marrow before separation of
the aggregates and collagenase treatment. Each animal was analyzed individually; cells
from both femurs were pooled. Data on untreated bone marrow was taken from other
representative experiments in the notebook. Statistical analysis was by t-test.
Long Term Bone Marrow Culture. LTBMC-B cultures were performed as described
(Chapter II). The medium used for LTBMC-B contained serum lot 11112034 (Hyclone,
Logan UT). Medium for LTBMC-M was Fisher's medium supplemented with 20%
selected FBS (Lot 11111087, Hyclone), 2mM L-glutamine, 50 U/ml penicillin, and
50µg/ml streptomycin, and lo-6M hydrocortisone. LTBMC-M were maintained at 33°C
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at 5.0% C02 with medium replenishment once a week. Hemopoiesis was maintained in
these cultures for at least seven weeks.

The nonadherent cells were removed from

LTBMC-M at 5 weeks and found to be predominantly neutrophils by morphological
examination.

Cell Sorting.

Unfractioned collagenase treated marrow or collagenase dispersed

aggregate cells were washed and B220+ and - cells sorted as previously described
(Chapter Ill).

Colony-Forming Unit (CFU) Assays. Following collagenase digestion and/or FACS
sorting, cells were placed in colony-forming unit assays as described previously (Chapter
II and 111).

WEHI-3 cell conditioned medium, recombinant kit ligand (KL,

lOOng/ml)(Amgen, Thousand Oaks, CA), Interleukin-7 (IL-7, lOOOU/ml)(SterlingDrug,
Malvern PA, or Biosource, Camarillo, CA), recombinant Insulin-like Growth Factor-1
(IGF-1, 50ng/ml)(Biosource) were added at concentrations that exhibited maximal colony
formation (previously determined).

Limiting Dilution Analysis of Hematopoietic Precursors. BMS2 stromal cell line
(132, 134) or stromal cells removed from LTBMC-B were plated into 96 well plates
(BMS2 le>4/well, LTBMC-B 1.5xle>4/well) and allowed to grow overnight. BMS2 layers
were irradiated with 2500 rad and LTBMC-B stromal cells were irradiated with lOOOrad
from a

137

Cs source. This served to halt proliferation of BMS2 cells and prevent the

appearance of lymphoid cobblestones still associated with the LTBMC-B stromal cells.
The medium (LTBMC-M) was replaced 24 hr. after irradiation. After a further 24 hr.
dilutions of unfractioned marrow, deaggregated marrow, or dispersed aggregates that had
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been identically treated in collagenase, hyaluronidase, and DNase were added. At least
six dilutions steps differing by a factor of 2 to 5, i.e. 8xl04, 4xl04, lxl04, 5xl03, lx1<>3,
5x1Q2, were used with 20 replicate wells per step.

Cultures were incubated under

LTBMC-M conditions. At weekly intervals wells were scanned for the appearance of
foci containing at least 15 hemopoietic cells attached to or beneath the stromal cells
(cobblestone areas).

Analysis of limiting dilution data was performed as described

(178, 179). Linear regression analysis of this data yielded a straight line passing near the
origin indicating that a single, limiting cell type was being detected as described
(178, 179). All data presented had a correlation coefficient (r) of 0.93 or greater. The
frequency of cobblestone forming cells was calculated by Poisson statistics at 37% of
negative wells, using the linear regression equations derived.

RESULTS

Evidence that marrow celluwr aggregates reflect nonnal stromal!hemopoietic
interactions. Many bone marrow stromal cells are found enmeshed in cellular aggregates
(Chapter II). The staining pattern with two stromal cell markers, VCAMl and alkaline
phosphatase, retains the architecture seen in marrow sections (Chapter 11,67, 113). On
this basis it has been suggested that aggregates are naturally-formed and reflect native
hemopoietic-stromal cell contacts. VCAMl, expressed on stromal cells, and its ligand,
VLA-4, expressed on hemopoietic cells, are involved in the adhesion ofhemopoietic cells
to stromal cells in long term culture and antibodies to either disrupts lymphopoiesis in
LTBMC (113, 116). If the in vitro data truly reflects the function of VCAMl and VLA4

in vivo, then it should be possible to disrupt aggregates with antibodies to these proteins.
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By visual inspection it appeared that anti-VCAMl antibody, particularly in combination
with anti-CD44 antibody, led to partial disruption of the aggregates in vitro. However,
equal number and sized aggregates could not be placed into replicate tubes to test for
dispersion by antibody; hence, different numbers of cells released might be due to more
aggregates or smaller aggregates in a sample, not to better dispersion by antibody.
Therefore it was not possible to quantify aggregate dispersion in vitro.

Since the

percentage of cells recovered in aggregates has been uniform over a number of
experiments (Chapter II), it is reasonable that inhibition of molecules involved in the
adhesion between stromal and hemopoietic cells in vivo would be reflected in a decrease
in the fraction of cells present in aggregates. This would represent a quantitative way
to look for disruption of the aggregates. In addition, the constant blood flow through the
marrow would ensure that stromal cells were bathed in antibody whereas settling of
aggregates during in vitro disruption experiments likely prevented them from being
uniformly exposed to antibody.
Therefore, mAb M/K2 (113) was injected i. v. into mice to see if this treatment
caused disruption of the aggregates. A dose 50µg of antibody per animal was chosen
because that amount saturates cell surface VCAMl in the marrow within minutes after
injection and avoided modulation of the antigen from the cell surface (147). Figure lOA
shows that there was no alteration in total marrow cellularity in anti-VCAMl-treated
animals, indicating that there was no overt cell lysis or emigration from marrow caused
by the antibody within 15 or 30 minutes following injection. However, the number of
cells in aggregates was reduced significantly (p>0.025) by treatment with anti-VCAMl
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Figure 10. Effects of anti-VCAMl antibody M/K2 on bone marrow cell aggregates. A)
Marrow cellularity in each experimental group. Each dot represents one animal, the

+

denotes the average for each group. There was no significant difference between any of
the groups. B) Percentage of total marrow present in aggregates. Treatments with M/K2
for 15 and 30 minutes were significantly different (p>0.025) from control groups.
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antibody at either time point as compared to control animals (Figure lOB).

The

aggregates that remained contained culturable stromal cells at a frequency identical to that
in control animals (data not shown), so it is unlikely that the disruption observed was due
to lysis of stromal cells. This result strengthens the argument that the aggregates reflect
typical cellular interactions occurring between stromal cells and hemopoietic cells in
normal animals. This data also implicates VCAMl in the adhesion of these cells in
aggregates.

Frequency of early hemopoietic stem cells in aggregates. Highly enriched stem cells
and B cell precursors use VLA4 to bind to VCAMl on cultured stromal cells (118, 119).
VCAMl expressing stromal cells are enriched in aggregates (Chapter II), therefore it
seemed likely that hemopoietic stem cells would also be sequestered there. LTBMC-M
cultures established readily from at least 50% fewer aggregate cells (data not shown) than
were required of unfractioned marrow, demonstrating the presence of hemopoietic stem
cells within the aggregates.
To address whether stem cells were indeed more frequent in the aggregates than
in unfractioned marrow, the cobblestone-area-forming cell (CAFC) assay, a limitingdilution assay to derive the frequency of the earliest hemopoietic stem cells, was
performed. Several authors have equated the appearance of cobblestone areas at given
time points with the primitiveness and self-renewal capacity of the stem cell (25,26,27).
Two types of irradiated feeder layers were used, the stromal cell line BMS2 (132, 134)
and primary adherent cells (stromal cells and macrophages) from LTBMC-B. Both of
these have been shown to support the development of hemopoietic cells in LTBMC-M
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conditions ( 131, 132, 134). Cells from unfractioned marrow, deaggregated marrow, or
aggregates were identically treated with collagenase/hyaluronidase and seeded onto feeder
layers at various dilutions and the presence or absence of cobblestone areas within a well
was scored at 7, 14, 21, and 28 days after seeding in LTBMC-M conditions. The results
are presented as semi-log plots of the percent of wells without cobblestone areas. A
linear regression line calculated from the data passes very close to the origin, indicating
that a single, limiting cell type is being detected, in agreement with previous
investigations (25,26,178,179). The point at which this line intersects 37% negative
wells is the frequency of that stem cell type in the fraction examined. The data show that
aggregates had a 3 to 4 fold higher frequency of CAFC than unfractioned collagenase
treated marrow at all days tested (Figure 11, Table 10). Deaggregated marrow, on the
other hand, usually contained CAFC only in proportion to its relative cellularity and the
frequency of CAFC in deaggregated collagenase treated marrow was not significantly
different from that for unfractioned collagenase treated marrow.

Hence, aggregates

contained 20-25% of all CAFC per femur while comprising only 6-7% of marrow cells.
This demonstrated that early stem cells are sequestered in the aggregates, presumably in
close association with stromal cells.

Content of clonogenic myeloid progenitors. Cells capable of forming cobblestone areas
at day 28 have been correlated with marrow repopulating ability whereas later, more
restricted cells are capable of forming splenic colonies (CFU-S) in lethally irradiated
animals (25).

Bone marrow progenitor cells highly enriched for CFU-S have been

reported to proliferate in culture in response to IL-3 and kit ligand (KL)(l80). Colony
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Figure 11. Limiting dilution analysis of early hemopoietic stem cells. Unfractioned
marrow(+), deaggregated marrow(•), and aggregates(•) were identically treated with
collagenase and hyaluronidase and multiple dilutions were plated onto irradiated BMS2
stromal cells. A cobblestone area was counted as a focus of 15 or more hemopoietic
cells attached to or beneath the stromal cells. Data are presented as linear regression
lines with input cell number on the x-axis and percentage of negative wells (without
cobblestone areas) on the y-axis. The line at 37% negative wells intercepts the lines at
the frequency of the progenitor type being measured. The linear regression lines pass
close to the origin, indicating that a single, limiting cell type is being measured.
Correlation coefficients (r) for all data presented

~

0.93. A) Cobblestone area forming

cells at day 7 of culture. B) CAFC at day 14. C) CAFC at day 28. This is the first of
three experiments shown in Table 1.
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Table 10.--CAFC Frequency in Bone Marrow Fractions
Cobblestone-Area Forming Cells

Cells/femur
(10-6)
Unfracb

Deaggb

Aggb

Day7

Dav 14

Dav 21

Dav 28

1/Freq!

1/Freq.

1/Freq.

1/Freq.

I

10.9

8,496

20,621

41,334

35,565

II

13.0

6,524

16,766

18,705

19,313

III

17.8

10,244

13,838

N.I.c

N.I.

I

5.9

10,244

42,809

31,506

55,141

II

6.5

3,343

9,629

15,232

41.465

III

8.7

9,102

9,068

N.I.

N.I.

I

0.4

2,657d

6,067

13,735

10,990

II

1.2

1,817

5,293

13, 114

14,019

III

0.7

2,791

6,057

N.I.

N.I.

•Calculated from the intercept of the linear regression plots in Figure 2 with 37% negative wells. Correlation coefficients (r) for
all data shown ~ 0.93. b Treated with collagenase and hyaluronidase. c N.I. Not Interpretable. d Aggregates days 7 & 14 were
significantly different from unfractioned marrow by t-test (p > 0.01). Deaggregated marrow was not significantly different. Too few
samples to determine significance on day 21 & 28, but a similar trend is seen.
::S
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Figure 12. Clonogenic myeloid precursors in bone marrow fractions. Unfractioned,
deaggregated, or aggregate cells were identically treated in collagenase and hyaluronidase
and plated in soft agar culture with WEHI-3CM, SCF, or both and incubated for 6 days.
Data shown are the mean

± S.D. of at least three plates.
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formation in the presence of IL-3 and KL was used to assess the frequency of immature
factor dependent but stromal cell independent hemopoietic progenitors in marrow
fractions (181,182). The results showed very little difference in the CFU-c frequency
potentiated by WEHI3-CM (IL-3) between the marrow fractions; moreover, addition of
rodent KL revealed no further differences (Figure 12). Some colony stimulating activity
was noted from KL alone, as has been reported previously (181,182,ChapterIII). Taken
together, only the most primitive hemopoietic stem cells appeared to be sequestered
within aggregates, whereas later, yet still immature myeloid restricted cells, capable of
proliferation in response to growth factors alone, were not.
Content of lymphoid progenuors. Early B-cell precursors expressing TdT are 3-4 fold
enriched in aggregates, whereas later stages in B-cell maturation (CFU-IL-7 and sigM+)
are not enriched or are even somewhat depleted (Chapter II). Until recently assays to
measure B-cell progenitors prior to B220(CD45RA) expression were lacking. Landreth

et al. reported that the combination of IL-7 and Insulin-Like Growth Factor-1 (IGF-1)
in short term liquid culture potentiates the differentiation of B220(CD45RAY bone
marrow cells to become cµ+ (40). Experiments were designed to see if this activity
could be reproduced clonally in semi-solid culture, enabling quantitation of
B220(CD45RAY B cell precursors. B220(CD45RAY bone marrow cells were purified
by cell sorting and placed in soft agar culture with growth factors.

As previously

observed, IL-7 alone resulted in no colony formation by B220(CD45RAY cells (Figure
13)(34,35,Chapter III). Unfractioned and B220(CD45RAY marrow cells yielded a few
colonies in response to IGF-1 alone, a majority of which were myeloid (Table 11, Figure
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13 and 14). The combination of IL-7 and IGF-1, however, led to the formation of a
small but consistent number of colonies (20-30 colonies per lOS cells) from
B220(CD45RAY marrow cells (Figure 13). These colonies were >95% lymphoid and
µ + whether they originated from unfractioned or B220- marrow (Table 11, Figure 14).

The addition of KL did not enhance the number of lymphoid colonies formed in the
presence of IGF-1 and IL-7 (data not shown).
This system was then used to determine the frequency of B220(CD45RAr B cell
precursors in the bone marrow aggregates as compared to unfractioned marrow. B220cells were isolated by F ACS sorting from dispersed aggregates or unfractioned marrow
and placed in soft agar culture containing growth factors. No differences were noted in
the frequency of colonies formed in response to IGF-1 and IL-7 (Figure 15), implying
that aggregates were not enriched in this early B cell progenitor. Although collagenase
treatment has not affected cells in other functional assays (3), the possibility that the
B220- precursors in aggregates are especially sensitive to collagenase treatment, which
could alter their functional characteristics, cannot be completely excluded.
CONCLUSIONS
The results presented here extend previous work characterizing the hemopoietic
cells entwined with stromal cells in the bone marrow. These experiments lead to the
following conclusions: 1) the adhesion of cells in aggregates is mediated at least in part
by the VCAMl molecule, 2) aggregates are enriched in CAFC, a measure of primitive
hemopoietic cells, 3) aggregates are not enriched in hemopoietic precursors responsive
to IL-3, with or without KL, in culture, 4) the combination of IL-7 and IGF-1 stimulates
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early B cell precursors in culture, and 5) aggregates are not enriched in B cell precursors
that respond to IL-7 with IGF-1.
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Figure 13. Colony formation in response to IGF-1, IL-7, or IGF-1

+ IL-7. Unsorted

or B220- cells were isolated by sorting from noncollagenase treated marrow and plated
in soft agar culture with growth factors for 6 days. Data shown are the mean
of at least three plates.

± S.D.
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Figure 14. Morphology of cells responding to growth factors. A) Unfractioned marrow
with IGF-1 alone, B) Unfractioned marrow with IGF-1 + IL-7, and C) B220- marrow
cells with IGF-l+IL-7.
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Table 11.--Phenotype of Cells in Colonies
Percent of Total•

Cells

Condition

Lymphoidb

Myeloidb

u+c

Unsorted

IL-7

99.0; 98.4d

1.0; 1.6

95.3

IGF-1

12.7; 7.0

76.5; 75.0

N.D.

B220-

IGF-1

+ IL-7

95.2; 99.0; 97.2

4.8; 1.0; 2.8

N.D.

IGF-1

+ IL-7

98.1; 95.6; 95.9

1.9; 4.4; 4.1

lOOC

• A minimum of 100 cells were scored per slide except where noted.
Jenner/Giemsa stain.
experiments.

c

c

N.D.; Not Done.

b Assessed by morphology after

Stained for total µ. immunofluorescence. d Each number represents analysis of pooled colonies from individual

Only 30 cells seen on this slide.

~

108

Figure 15. B cell progenitors responsive to IGF-1 + IL-7 in bone marrow fractions.
B220- cells were isolated by cell sorting from noncollagenase treated unfractioned
marrow or collagenase dispersed aggregates and plated in soft agar culture with growth
factors for 6 days. Data shown are the mean

± S.D. of at least three plates. We have

reported that our collagenase treatment does not affect IL-7 responsiveness (3).
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Chapter V
ENRICHMENT OF STROMAL CELLS DIRECTLY FROM BONE MARROW
CELL SUSPENSIONS AND ANALYSIS OF THEIR CYTOKINE PRODUCTION

111
ABSTRACT

Several studies have used in vitro derived stromal cell lines to analyze stromal cell
functions. However, such cell lines have proven to be heterogeneous by a number of
criteria. The primary goal of this dissertation has been to identify and analyze stromal
cells directly from bone marrow cell suspensions. In this chapter a gentle centrifugation
technique was developed that allows stromal cells to be seen immediately after
collagenase digestion of aggregates.

Immunomagnetic separation of cells expressing

VCAMl enriches for cells with stromal cell characteristics, enabling histochemical and
immunocytochemical studies to be performed. Freshly isolated stromal cells express
alkaline phosphatase, VCAMl, a-actin, and about 50% express weak naphthyl esterase
activity. These cells also express IL-7 protein and about 50% express KL, but only a
few express M-CSF. These results present some contrasts to the stromal cells derived

in vitro. These studies are the culmination of this dissertation project.
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INTRODUCTION
The best avenue to assess biologic activity of any cell type is to study its activity

in vivo. While this is relatively easy for cell types such as lymphocytes, which can be
isolated quickly and in large numbers, stromal cells constitute only a minor fraction of
bone marrow cells and are tightly entwined with hemopoietic cells, making their isolation
difficult (Chapter II and IV). Stromal cells have been defined in this dissertation by their
morphology, alkaline phosphatase activity, and VCAMl expression. However, stromal
cells can only be counted after 48 hours of culture; no attempts to identify fresh stromal
cells have been made. Further enrichment of stromal cells is necessary in order to have
sufficient quantities for analysis.

Since VCAMl has been found to be constitutively

expressed on stromal cells, it seemed logical to use that marker to further enrich stromal
cells.

Several methods are available to purify cells based on their expression of

phenotypic markers: 1) fluorescence activated cell sorting (FACS), 2) panning, and 3)
immunomagnetic separation. Each of these techniques has particular advantages and
disadvantages so the optimal isolation protocol must be tailored to individual cell types.
The objectives of this study are to identify stromal cells directly from cell suspensions
of dispersed aggregates and to enrich stromal cells further so that their production of
lymphopoietic growth factors can be analyzed.

MATERIALS AND METHODS
Cell Preparation and Isolation of Aggregates. Aggregates were isolated from marrow
cell suspensions and dispersed in a cocktail of collagenase and hyaluronidase as described
(Chapter II and IV).
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Immunomagnetic Separation of VCAMl-Positive Cells.

Goat anti-rat IgG (Fe

specific) magnetic beads (Advanced Magnetics, Cambridge MA) were incubated for 15
minutes at 4°C with lOµg/ml rat IgG (chromatographically purified, Sigma, St. Louis,
MO) or a 1:500 dilution of M/K2 ascites prepared in SCID mice (113,116)(rat antimouse VCAMl, American Type Culture Collection, Rockville, MD) then washed three
times with RPMI supplemented with 10% heat-inactivated FBS. A bead:cell ratio of
40: 1 was chosen by titration experiments based on the bead: cell ration used to isolate
endothelial cells (183). Cells were incubated for 20 minutes at 4°C with rat IgG coated
beads. Cells that bound rat IgG nonspecifically were then removed using a Biomag
Separator (Advanced Magnetics). Negatively selected cells from this step were then
incubated for 20 minutes with mAb M/K2 (anti-VCAMl) coated beads. Cells were then
subjected to another round of magnetic separation. Immediately after separation and
without washing, approximately H>5 positively selected cells were placed onto Superfrost
glass microscope slides (Fisher, Pittsburgh, PA) coated with lOµg of CelTak
(Collaborative Biomedical Products, Bedford MA)(99) and incubated at 37°C in a
humidified incubator for 1 hour.

The slides were then centrifuged at 350rpm in

microplate carriers in a Beckman GPR centrifuge with rotor GH3. 7 (approximately 30
X g) and subsequently then stained for alkaline phosphatase (Kit 86C, Sigma), acid
phosphatase (kit 386-A), naphthyl esterase (kit 91-A), chloroacetate esterase (kit 91-C),
or acetyl cholinesterase (184) activity.
Induction of Osteocalcin Expression. The MC-3T3-El osteoblastic cell line (185) was
kindly provided by Drs. J. Stein and J. Lian, Univ. Mass. Med. Cntr., Worcester, MA.
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MC-3T3-El cells were cultured in aMEM with 10% PBS.

To induce osteocalcin

expression El cells were cultured in 35mm culture dishes with ascorbic acid and Bglycerol phosphate (Sigma, St. Louis, MO) according to the method of Quarles et al.
(186) Medium was replaced once a week and cells were used 23 days after being placed
under inducing conditions.
Immunocytochemical Staining for Intracellular Cytokine Proteins. Cells on CelTak
coated slides were sometimes held in tubes with desiccant overnight before staining.
Cells were fixed for 15 minutes in ice cold 95 % ethanol with 5 % acetic acid. The slides
were then washed 3 times in PBS. Endogenous peroxidase activity was blocked with
0.3% H 20 2 in methanol for 30 minutes at room temperature and the slides were again
washed 3 times in PBS. At this point the cells were incubated for 1 hour with 50 %
donkey serum to block nonspecific binding of the primary antibody. Primary antibodies
included goat anti-mouse osteocalcin (serum, Biomedical Research Incorporated,), or
polyclonal rabbit anti-human IL-7 (affinity purified, cross reacts with mouse, Biosource,
Camarillo, CA) using 80µ1 per slide. The optimal concentration of serum for osteocalcin
(1:375 dilution, 4 hour incubation) staining was determined by titration on MC-3T3-El
cells induced to express osteocalcin.

Anti-IL-7 staining was used at a concentration

known to stain IL-7 expressing stromal cells from LTBMC-B (0.25-0.5µg, 121). Slides
were washed 3 times in PBS and stained with biotinylated donkey anti-goat or donkey
anti-rabbit IgG (Fab'2, heavy and light chains, Jackson Immunoresearch, West Grove,
PA).

After 3 more PBS washes, slides were stained with the Vector ABC Elite kit

(1:100, Vector, Burlingame, CA). Horseradish peroxidase enzyme activity was detected
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by immersing the slides in 0.45mg/ml diaminobenzidene (DAB, Sigma) for 15 minutes
in buffer containing 0.15M NaCl, 0.05M Tris, and 0.07% H20 2 • Slides were counter
stained in hematoxylin, washed, dried, and observed by bright field microscopy.
Antibodies to kit ligand and M-CSF appeared to stain faintly with DAB reaction
product on VCAMl selected cells, so I tried alkaline phosphatase visualization of
antibody binding, hoping that the color contrast between positive and negative cells
would be easier to judge. Cells to be stained for kit ligand or M-CSF protein were fixed
and washed as above. Cells were then incubated with rabbit anti-mouse KL (5µg/ml,
overnight incubation, polyclonal, protein A purified, Genzyme, Cambridge, MA) or goat
anti-mouse M-CSF (1:200 dilution for 1 hour, serum, kindly provided by Dr. E. R.
Stanley, Albert Einstein College of Medicine, Bronx, NY) using 80µ1 per slide. Both
of these antibodies were titered by staining adherent cells from LTBMC-B.

After

washing and staining with appropriate secondary reagents as above, antibody binding was
visualized using an alkaline phosphatase kit (Vector) with blue substrate in the presence
of lµl levamisole per 80µ1 to block endogenous alkaline phosphatase activity. Slides
were counter stained with neutral red and observed by bright field microscopy.
Immunofluorescence Microscopy. Cells on CelTak coated slides were fixed in ice cold
95% ethanol and 5% acetic acid. The slides were then washed 3 times in cold PBS.
Following the washes, the cells were stained with 80µ1 per slide of a 1:300 dilution mAb
1A4 (mouse anti-a-actin, Sigma) for 30 minutes in a humid chamber.

Slides were

washed again in PBS then stained with 80µ1 per slide of a 1:30 dilution of FITC
conjugated goat anti-mouse IgG (Fab'2, Jackson Immunoresearch) for 30 minutes. The
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slides were washed a further 3 times in PBS, mounted in phosphate-buffered glycerol,
and observed by epifluorescence microscopy.
RESULTS

Visualizing Stromal Cells from Aggregates.

Previous studies have dealt with the

enrichment of stromal cells in cell aggregates present in bone marrow suspensions
(Chapter II and IV). Therefore, collagenase dispersed aggregates were the starting point
in attempting to identify fresh stromal cells. Following gentle centrifugation of cells
from collagenase dispersed aggregates onto CelTak coated slides, a rare type of large,
alkaline phosphatase positive cell was seen (Figure 16A). Such a cell could not be found
on conventional cytocentrifuge preparations. These large cells were usually seen with
hemopoietic cells still attached. Their size, oval nucleus, alkaline phosphatase reactivity,
and apparently stable attachment to hemopoietic cells were consistent with criteria for
stromal cells.

Therefore, these cells were tentatively identified as stromal cells.

Unfortunately, the low incidence of cells with this morphology precluded preparing them
in sufficient numbers for further analysis.

Furlher Enrichment of Stromal Cells. There are currently no specific markers for
stromal cells.

VCAMl has been used as a criterion to identify stromal cells since

VCAMl is expressed on reticular cells in the marrow and in aggregates, on short-term
cultured stromal cells, and long-term cultured stromal cells (113,116,121,147, Chapter
II). Therefore, further enrichment of stromal cells was attempted based on expression
of VCAMl. Initially, FACS was tried because it is a well established method to purify
cells and I am fairly familiar with its use. In these experiments collagenase dispersed
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aggregate cells were directly sorted into 24 well plates and counted after 48 hours
incubation. Fewer stromal cells were found on these plates than were present in the
dispersed aggregates before sorting. Turbulence in the sort stream could have destroyed
the fragile stromal cells. Therefore, I used increased sort nozzle diameters up to 200µm
to slow the sort rate and provide a less turbulent sort stream. These experiments also
appeared to destroy stromal cells.

Next I tried immunoadsorbent separation on

polystyrene plates, commonly called panning, using anti-VCAM coated plates. This
technique did deplete the VCAM negative population of stromal cells and, if positively
selected cells were left on the plate under LTBMC-B conditions, stromal cells were
present after 48 hours incubation. However, removing the positively selected cells from
the plate requires scraping, which would likely destroy the stromal cells.
Immunomagnetic separation was used next as a gentler enrichment protocol.
Magnetic beads coated with Ulex europaeus agglutinin have been used to isolate
endothelial cells (183), which may be physically similar to stromal cells.
Immunomagnetic separation of VCAMl positive cells, using 40 beads per cell (183),
yielded enrichment of cells with morphology similar to those seen previously from
collagenase dispersed aggregates (Figure 16B). In experiments using bead:cell ratios
lower than 40: 1 these cells did not appear to be as enriched or to segregate exclusively
into the VCAMl + fraction. In 7 experiments, 7.4

± 3.0% of collagenase dispersed

aggregate cells separated into the VCAMl positive fraction. The content of stromal cells
in the VCAMl +fraction was verified by morphology and alkaline phosphatase staining.
In three separate experiments 23. 7 + 3.8% of the VCAMl positive cells had a stromal
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cell morphology and almost all of these were alkaline phosphatase positive (Table 12).
This leads to an estimate of 1.2 X 1Q4 stromal cells in aggregates per femur. This means
that stromal cells are 237 times more frequent in VCAMl positive cells than in
collagenase-digested, unselected aggregates and about 700 times more enriched than in
unfractioned marrow.

However, in must be noted that this is a comparison of the

frequency of freshly isolated stromal cells to the frequency of culturable stromal cells in
unselected aggregates. Cells with stromal morphology were always surrounded by many
magnetic beads, often being partially obscured by them, which suggested that these cells
expressed the VCAMl molecule. Hemopoietic cells were also seen on these slides but
were rarely in close contact with magnetic beads, suggesting that they were VCAMlcontaminants. Some megakaryocytes appeared on these slides as well, always in contact
with beads. Identification of megakaryocytes was confirmed by acetyl choline esterase
(AChE) staining which clearly distinguished them from the alkaline phosphatase positive
cells which were acetyl cholinesterase negative (184).
No cells with stromal cell morphology were seen on identically prepared slides
with VCAMl- cells.

The morphology of the alkaline phosphatase positive cells was

again quite distinct, being large cells with relatively clear cytoplasm and an oval nucleus.

Based on their morphology, alkaline phosphatase reactivity, and segregation into the
VCAMl positive fraction these cells fulfill all of the criteria used to identify stromal

cells throughout this dissertation and will, therefore, be referred to as stromal cells.
Phenotype of VCAMl Positive Stromal Cells. Bone marrow contains several cell types
which could be the in vivo equivalent of cultured stromal cells including endothelial cells,
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Figure 16. Alkaline phosphatase positive (blue deposit) cells with stromal morphology.
A) Alkaline phosphatase positive cell from collagenase dispersed aggregates on CelTak
coated slide. Note hemopoietic cells still attached. B) Alkaline phosphatase positive
cell from VCAMl positive fraction on CelTak slides. Note that alkaline phosphatase
activity (small arrow) is much lower after immunomagnetic separation. Also note the
magnetic beads surrounding cell. Both photos 630X original magnification.
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osteoblasts, macrophages, reticular cells, and bone lining cells. Therefore, a series of
histochemical assays and antibody staining experiments was performed to characterize
the putative stromal cells and possibly further define their lineage (Figure 17, 18, and
19, Table 12 and 13).

As stated, virtually all cells with stromal cell morphology

expressed alkaline phosphatase reactivity, although this activity was weak possibly due
to the isolation procedure. Approximately half of the stromal cells exhibited a low level
of staining for naphthyl esterase but all were negative for acid phosphatase, chloroacetate
esterase, and AChE (Figure 17, Table 13). The level of staining for naphthyl esterase
was clearly below that of monocytes from the bone marrow. As well, the regular shape
of the nucleus and clear cytoplasm distinguish these cells from monocytes/macrophages
(Figure 17 A and B)(l87,188).

Osteocalcin is a bone matrix protein produced

exclusively by osteoblasts, and it has been suggested that marrow stromal cells may be
related to osteoblasts (81, 103).

However, VCAM 1 positive stromal cells exhibited

undetectable levels of osteocalcin (Figure 18 A, B, and C), suggesting that they are
distinct from at least the later stages of osteoblast differentiation. Stromal cells were
invariably uninucleate and acid phosphatase negative (Table 13), distinguishing them
from osteoclasts (79). Lack of acetyl cholinesterase activity distinguished stromal cells
from megakaryocytes (Table 13)(184). In addition, megakaryocytes routinely had a more
complex nucleus and cytoplasm than stromal cells, making them easily distinguishable
from stromal cells by morphology alone.

Lack of chloroacetate esterase activity

distinguishes stromal cells from granulocytes (Table 13).
Stromal cells in culture express the a isoform of actin (a-actin)(l38, 139, 140, 189).
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This actin isoform is normally found in smooth muscle cells and pericytes, cells which
line the abluminal wall of small blood vessels outside the reticuloendothelial system
(190,191). The stromal cells studied here also possessed a-actin filaments as evidenced
by indirect immunofluorescence staining with monoclonal antibody against a-actin,
strengthening the comparison between these uncultured VCAMl positive cells and
stromal cells in culture (Figure 19, Table 13). However, the staining of the freshly
isolated cells was much less intense than that in stromal cells from LTBMC-B.

Cytokine Protein Production by VCAMl Positive Stromal Cells. Based on the above
results, the VCAMl + stromal cells appear to be relatively free of potential contaminating
cells and are present in sufficient quantity to examine their production of three cytokine
proteins, IL-7, kit ligand, and M-CSF, was examined by immunocytochemistry (Figure
20, Table 14). Over 80 percent of the stromal cells expressed IL-7 (Figure 20 A and B),
between 50 and 60 percent stained positively for kit ligand (Figure 20 C and D), and less
than 7 percent stained with antibodies to M-CSF (Figure 20 E, F, G, and H). No cells
staining positively for IL-7 or KL were found among the VCAMl- cells. Only a small
percentage of cells staining for M-CSF appeared among the VCAMl- cells, these were
judged to be monocytes by their morphology. Therefore, stromal cells in the marrow
do produce cytokines that help support hemopoiesis, and production of IL-7 and KL
appears to be a stromal cell specific function.

However, the pattern of cytokines

produced by fresh stromal cells can vary considerably from that seen using cultured
stromal cell lines (see DISCUSSION).
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CONCLUSIONS

The results presented here are the first studies to identify and examine marrow
stromal cells without intervening culture. This is also the first demonstration of cells
from the marrow producing IL-7, kit ligand, and M-CSF. These studies lead to the
following conclusions; 1) marrow stromal cells are very fragile and can only be
visualized by adopting very gentle centrifugation techniques, 2) marrow stromal cells are
rather homogeneous in their expression of alkaline phosphatase and a-actin but
heterogeneous

in

expression

of naphthyl esterase,

3)

after enrichment by

immunomagnetic selection morphologically identifiable stromal cells are distinguishable
from osteoblasts, macrophages, hemopoietic cells, megakaryocytes, and most endothelial
cells, 4) nearly all stromal cells in young adult mice possess IL-7 protein and about half
possess detectable KL protein, 5) in marked contrast to stromal cell lines, few fresh
stromal cells possess M-CSF protein.
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Table 12.--Cells Expected to Stain with Lineage Markers
Stain

Positively Staining Cells

Alk. Phos.

Osteoblasts, Fibroblasts, Reticular cells,
Granulocytes (weak)

Acid Phos.

Neutrophils, Most Leukocytes

Naph. Estr.

Monocytes

Chloro. Estr.

Granulocytes

AChE.

Megakaryocytes

a-actin

Smooth muscle, pericytes

oc

Osteoblasts

Table 13.--Phenotype of VCAM + Stromal Cells
Percent Positive•
Expt.

A 1 k .
Phos.

A c i d
Phos.

Nap h.
Estr.

Chloro.
Estr.

AchE.

a-actinb

occ

1.

86.0

0

57d

0

0

94

1

2.

98

0

43

2

0

78

0

3.

96

N.D.

41

N.D.

N.D.

72.7

N.D.

• All values are the average of at least two slides, 100 stromal cells were scored per slide. b Detected by indirect
immunofluorescence, 50 stromal cells scored per slide.
d

c

Detected by immunocytochemistry, 100 stromal cells scored per slide.

Intensity level of naphthyl esterase stain on stromal cells was always lower than that on bone marrow monocytes (see Figure 17).

~
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Figure 17.

Naphthyl esterase staining (black dots indicated by small arrows).

Esterase positive monocyte from VCAMl

negative fraction,

A)

lOOOX original

magnification. B) Esterase negative stromal cell at arrow, original magnification 630X.
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Figure 18. Anti-Osteocalcin staining of VCAMl positive cells. A) MC-3T3-El cells
induced to express osteocalcin stained with goat anti-osteocalcin antiserum. 630X B)
Induced MC-3T3-El cells stained with normal goat serum. 630X C) Stromal cell
stained with goat anti-osteocalcin antiserum. lOOOX
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Figure 19.

Anti-a-actin staining of VCAM + stromal cells.

A)

Phase contrast

photomicrograph of VCAM + stromal cell, note stromal cell nucleus at arrow. 630X
B) Fluorescence photomicrograph of same field showing green fluorescence, positive
staining for a-actin. 630X
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Figure 20. Anti-IL-7 and Anti-KL staining of VCAM + stromal cells. A) Stromal cell
stained with anti-IL-7, DAB visualization.

lOOOX B)

Stromal cell stained with

nonimmune rabbit IgG. lOOOX C) Stromal cell stained with nonimmune rabbit IgG,
visualised by blue alkaline phosphatase substrate. Note background staining at small
arrow. lOOOX D) Kit ligand positive stromal cell, note slightly more intense stain at
arrow. lOOOX
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Figure 21.

Anti-M-CSF staining of VCAM + stromal cells.

A) Stromal cell from

LTBMC-B stained with nonimmune goat serum, alkaline phosphatase blue substrate.
630X B) Stromal cell from LTBMC-B culture stained with goat anti-M-CSF. 630X C)
Stromal cell stained with normal goat serum at arrow. lOOOX D) Stromal cell with
positive staining for M-CSF, note blue deposit at arrow. lOOOX
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Table 14.--Cytokine Protein Production by VCAM + Stromal Cells
Percent Positive•
Expt.

IL-7b

Kit ligandc

M-CSP

1.

83.0

± 3.0

57.0

± 6.2

5.0

+ 2.0

2.

84.3

± 10.7

61.3

+ 4.9

6.3

+ 2.1

3.

84.0

± 1.0

53.0

± 1.7

5.3

+ 2.1

•All values are the average of three slides

± S.D. 100 stromal cells were scored per

slide, i.e. 300 stromal cells per experiment.
b Detected by immunocytochemistry with peroxidase/DAB visualization. c Detected by
immunocytochemistry with alkaline phosphatase visualization.
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Chapter VI
DISCUSSION
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The exact lineage derivation, location, function, and extent of heterogeneity of the

in vivo equivalent of cultured marrow stromal cells remain largely unknown. A number
of studies have used cultured stromal cell lines and clones in attempts to define the
characteristics of stromal cells (3,63,64, 122). However, these cell lines and clones are
heterogeneous by a number of criteria, making generalizations about stromal cells
difficult to draw. Therefore, I began with the goal of studying stromal cells enriched
directly from bone marrow cell suspensions. In addition to accomplishing this goal,
several interesting facets of stromal cell function and marrow structure have been
revealed. The major conclusions of this work are: 1) alkaline phosphatase and VCAMl
are phenotypic markers to define murine bone marrow stromal cells, 2) stromal cells are
selectively entwined with hemopoietic cells in the form of cellular aggregates, 3)
separation of these cell aggregates results in an enriched population of stromal cells, 4)
pre-B cells and TdT+ cells are enriched in the aggregates but clonable B cell precursors
are not, 5) aggregates are also enriched in stem cells but not clonable myeloid
precursors, 6) adhesion between cells in aggregates is mediated at least in part by
VCAMl, 7) separation of VCAMl + cells from aggregates results in enrichment of cells
with all of the hallmarks of stromal cells, 8) the VCAMl + cells do not possess
histochemical reactivity characteristic of other marrow cell lineages, with the exception
of weak naphthyl esterase activity, 9) most of these putative stromal cells express the
smooth muscle cell (ex) isoform of actin, 10) most of these stromal cells express IL-7,
about half express KL, and few express M-CSF.

Secondary, but still important

conclusions of this work are that IL-7 in combination with IGF-1 will generate pre-B
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lymphocytes from B220- marrow, forming a quantitative assay for 'pro-B' lymphocytes,
whereas KL in combination with IL-7 will not. These are all important advances in our
understanding of bone marrow structure, stromal cell function, and cytokine regulation
of B lymphocyte development. In particular, the availability of fresh stromal cells will
allow better understanding of the regulation of hemopoiesis in vivo.

Identification and Enrichment of Freshly Isolated Stromal Cells
The identification of stromal cells in this dissertation has relied on their
morphology, alkaline phosphatase activity, and expression of VCAMl. These markers
have been used by other investigators to define both cultured stromal cells and reticular
cells in vivo (67,113,116,147). In my hands, these markers define a population oflarge
adherent cells with oval nuclei that grow from bone marrow aggregates and adhere and
spread in 48 hour cultures of bone marrow. An unavoidable caveat of this work is the
lack of a discrete marker for stromal cells. Alkaline phosphatase can be expressed on
other cell types and VCAMl has been found on endothelial cells, synovial cells, and
dendritic cells (150). To date, no antibody has been found that specifically identifies
bone marrow stromal cells. However, using several criteria in combination should make
the identification more precise.
Because I was ultimately interested in isolating normal uncultured stromal cells
from bone marrow, I examined the relative frequencies of readily culturable stromal cells
from different bone marrow fractions. In murine bone marrow suspensions, stromal cells
are found in the highest frequency ( - 0.1 %) in large cellular aggregates as compared to
whole marrow or marrow that has been depleted of aggregates.

Nevertheless, the
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majority of stromal cells are not recovered by our procedures. I estimate that there are
about 4000 stromal cells per femur (-0.04% of total marrow) that are identifiable within
48 hours of culture, yet only 800 to 1000 per femur (-25% of total stromal cells) are
recoverable from aggregates. Deaggregated marrow, while containing roughly 60% of
the nucleated cells of whole marrow, has only about 100 recoverable stromal cells per
femur ( - 2.5 % of total stromal cells). Although the number of adherent stromal cells
from the central portion of the fetal bovine serum gradient was not determined, initial
plating experiments suggested that the smaller aggregates present there contained few
culturable stromal cells (Funk, personal observation). That fraction, therefore, is not
likely to contain more stromal cells than deaggregated marrow. The question remains,
where are approximately 70% of the stromal cells lost during the isolation procedure?
It is possible that many stromal cells are destroyed or lost in the collagenase digestion
procedure.

If this were the case, differences in stromal cell counts would be seen

between untreated marrow and unfractioned collagenase treated marrow (Table 3).
However, such differences are not apparent in the data.

Another possibility is that

stromal cells are lost while being placed on or being removed from the PBS gradient.
The aggregates themselves appear to be sticky and can be seen adhering to the walls of
the pipet while marrow suspensions are being loaded onto the PBS gradient.

In

addition, removal of aggregates from the gradient with a glass pasteur pipet could lead
to shearing of stromal cells in aggregates and would not be reflected in collagenase
treated whole marrow counts as these cells did not go through this procedure.
A few previous reports suggested that stromal cells may be present in aggregates
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with hemopoietic cells. Lanotte et al. (192) directly suggested that stromal cells are
present in multicellular aggregates. Whitlock et al. (105) commented on the necessity
of cell clumps for forming an adherent layer in culture. Crocker and Gordon (144) noted
an enrichment of alkaline phosphatase positive fibroblastic cells in clusters separated from
marrow suspensions, similar to the findings reported here.

Although Crocker and

Gordon focused on the enrichment of resident bone marrow macrophages, several key
observations were strikingly similar to those in this report. First, both studies show
approximately 7 to 8 % of total nucleated bone marrow cells are in clusters or aggregates.
Second, our data agree that alkaline phosphatase positive fibroblastic cells (presumably
stromal cells) are enriched approximately 3 fold in aggregates.

Third, both reports

document increased 3H TdR incorporation by aggregate cells in comparison with that by
whole marrow.
Another comparison to the cell aggregates found in mouse bone marrow is to the
hematon described in human marrow (145). However, a number of differences clearly
distinguish these elements. First, the hematon is noted for its lack of adherent cells,
although hematons contain adipocytes which are common in human marrow and may
derive from stromal cells (134), while aggregates are notably enriched for adherent cells.
Second, nucleated cells in hematons are in excess of 20% of total nucleated cells in
marrow aspirates while aggregates contain, on average, only 7% of cells in femoral
marrow. Third, unlike aggregates, hematons are enriched in CPU-GM. Nevertheless,
both hematons and aggregates may be representative of similar processes requiring
intimate association of stromal elements and developing hemopoietic cells.
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IMMUNOMAGNETIC ENRICHMENT OF STROMAL CELLS
Immunomagnetic separation of VCAMl +cells from dispersed aggregates further
enriches cells with stromal morphology to about 23 % of all cells present, an enrichment
factor of 237 fold over the frequency of culturable stromal cells in aggregates, and nearly
600 fold over the frequency of culturable stromal cells in unfractioned marrow. The
previous estimate of the frequency of stromal cells in aggregates was about 700 per
femur, based on their ability to attach and spread into morphologically identifiable
stromal cells by 48 hours of culture (Chapter II). The data from the VCAMl + stromal
cells leads to an estimate of 1.2 X la4 stromal cells per femur in aggregates. If one
takes 7 X

Hf as the average number of cells in aggregates then each stromal cell could

interact with about 58 (7 X 1<>5/1.2 X 1<>4) hemopoietic cells. Another consideration in
calculating the number of stromal cells present based on the number of freshly isolated
stromal cells is the cell loss that occurs during aggregate isolation and collagenase
digestion. If one assumes that 75 % of stromal cells are lost in this process as discussed
previously, then one calculates approximately 4.8 X la4 stromal cells per femur in total
bone marrow, or, assuming 1 X 107 total cells per femur, stromal cells would constitute
0.48% of the bone marrow cells. Even assuming a 90% loss of stromal cells in this
enrichment protocol, stromal cells would make up only 1.2 % of marrow cells. These
would seem to be fairly realistic estimates of the number of stromal cells within the bone
marrow.

ORIGIN OF CULTURED STROMAL CELLS
Comparison of the numbers of freshly isolated stromal cells to culturable stromal
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cells in aggregates also suggests that as few as 6 % of stromal cells in the marrow
(700/1.2 X 104) survive in culture for 48 hours.

Whether these surviving cells can

proliferate to form all of the stromal cells found in LTBMC cultures or if LTBMC
stromal cells arise from a mesenchymal precursor is only now amenable to study. Intact
aggregates appear essential to the formation of the adherent layer in LTBMC conditions
(Chapter II and IV, 105) but, given their rarity, it is unclear if they can account for all
of the stromal cells found in mature LTBMC.

Other authors have reported the

generation of stromal cells from isolated mesenchymal precursors in culture (99, 101, 198)
and this may be the main source of in vitro stromal cells. I have been unable to culture
the stromal cells isolated by immunomagnetic selection. This could be due to damage
to the cells during the isolation process, the beads may interfere with their ability to
attach to the culture dish, or these could be mature cells incapable of growing in culture.
If methods can be found to culture out these stromal cells their ability to proliferate in

vitro can be assessed, possibly giving insight into the potential existence of stromal cell
precursors.

Differentiation of stromal cells from precursors in artificial in vitro

conditions raises the possibility that the resulting stromal cells possess an equally
artificial phenotype, making it unclear if the stromal cells found in vitro are equivalent,
or even relevant, to the stromal cells in vivo.

This underscores the importance of

studying freshly isolated stromal cells.
EXP~SION

OF VCAMl BY MARROW CELLS

The close association of the stromal cells described here with the anti-VCAMl
coated beads, as well as their exclusive segregation into the VCAMl positive fraction,
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suggests that they are truly VCAMl positive. However, since the fresh stromal cells
could not be cultured it was not possible to independently confirm their expression of
VCAMl. Most of the other cells in the VCAMl positive fraction were not closely
associated with the anti-VCAMl coated beads, suggesting that about 75 % of the selected
cells were nonspecific contaminants. Notably, some megakaryocytes were seen attached
to the beads. However, some megakaryocytes were also found in the VCAMl negative
fraction.

This could mean that these megakaryocytes express VCAMl or that they

passively acquire VCAMl from other cells during the isolation process. Megakaryocytes
in the VCAMl positive fraction were easily distinguished from stromal cells by their
size, cytoplasmic complexity, nuclear morphology, and acetyl choline esterase staining.
Such contaminating cells could be present because of the relatively high bead:cell ratio
used, making it more likely that cells could nonspecifically associate with beads.
However, experiments using lower bead:cell ratios were not as useful in separating
stromal cells.
The criteria used to judge stromal cells were rather conservative and have been
used by other investigators. This was done so that identification of a cell as stromal
could be done with confidence. A limitation with this technique is that the magnetic
beads present on the slides could obscure cells. This would introduce some bias into the
results since the nuclear morphology of the cell was critical to identification of stromal
cells. Such a bias would lead to an underestimation of the number of stromal cells
present.

Obscuring of cells by the magnetic beads would likely be a random event

depending on how the cells settled onto the slides, unless a particular subpopulation of
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stromal cells had especially high levels of VCAMl on the cell surface. If that were the
case, that subpopulation, with its potentially unique properties, would not be accounted
for in these studies. However, similar numbers of stromal cells were repeatedly found
after the immunomagnetic separation protocol, suggesting that this method is
reproducible. Electron microscopic analysis of cells enmeshed in the beads would allow
any stromal cells present there to be analyzed. The principal cell type that could be
confused with stromal cells in these studies was endothelial cells, which comprised about
12 % of the cells identified as stromal, as assessed by uptake of acetylated low density
lipoprotein.

Double staining experiments with endothelial cell markers would allow

endothelial cells to be completely eliminated from being scored as stromal cells.
It has been proposed that stromal cell subsets exist that differ in their

lympho/hemopoietic support capacity. However, stromal cells in primary culture appear
homogeneous

by

several

criteria;

including

the

expression

of

VCAMl

(113, 116,118, 119, 121), MECAlO (96), 8.28(121), a-actin(138-140, 189), collagens I and
IV (96), and laminin (96).

The fresh stromal cells reported here are also rather

homogeneous in their phenotype, being VCAMl +,alkaline phosphatase positive, a-actin
positive, and acLDL negative, suggesting that distinct subsets of stromal cells might not
be present in vivo. This view is also supported by the ability of LTBMC stromal cells
to support both lymphopoiesis and myelopoiesis under appropriate conditions (131,135).
The only criteria noted here that could define stromal cell subsets are naphthyl esterase
activity and expression of KL. Double staining for these markers could determine if they
were coincident on the same cells or mutually exclusive. These experiment_s would be
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needed to look for evidence of distinct stromal cell subsets within the marrow.

IN VIVO CORRELATE OF STROMAL CELLS
The most likely in vivo correlate of the cells studied here is the reticular cell of
the bone marrow. Reticular cells in vivo express alkaline phosphatase and VCAMl, as
do the stromal cells studied here (66,67,113,147). Reticular cells in vivo also possess
actin filaments, although the specific isoform of actin has not been determined (65). As
yet there is no specific marker for bone marrow reticular cells, so conclusive
demonstration that these are reticular cells is not possible. Bone lining cells have only
been studied recently and possible phenotypic markers have not been described (73,74),
although Westen and Bainton describe alkaline phosphatase activity in the endosteal
region of the marrow, possibly including the bone lining cells (67).
The stromal cells described here are not differentiated osteoblasts as they fail to
stain with antibodies to osteocalcin, a bone matrix component produced by osteoblasts
(80,81). Isolation of osteoblasts requires repeated collagenase digestion of bone slices,
so it is unlikely that simply flushing marrow from the bone shaft would dislodge many
osteoblasts (80,81,82). These stromal cells can also be distinguished from macrophages
by their relatively clear cytoplasm, expression of alkaline phosphatase, and clearly lower
levels of naphthyl esterase activity.
The uncultured stromal cells studied here were found to possess cx-actin filaments
as do stromal cells in vitro (138,139,140,189). Smooth muscle cells, while present in
the marrow, are extremely rare and are found lining arterial vessels, not among the
hemopoietic cells (61). Galmiche et al. have recently reported that stromal cells in
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culture express other markers of smooth muscle cells (189). However, they report that
stromal cells originate from a-actin negative precursors in culture, making it possible that
a-actin expression is induced by culture conditions. Nevertheless, expression of a-actin
makes it possible that stromal cells in vivo are smooth muscle-like, contractile cells with
the ability to actively sort hemopoietic cells as adventitial reticular cells are proposed to
do (65).

Further studies utilizing other markers of smooth muscle cells would be

required to determine if stromal cells are smooth muscle in origin. VCAMl is expressed
briefly during development of skeletal muscle (193) but it has not been reported in
smooth muscle cells.
Another cell type known to express a-actin is the pericyte, a cell found lining the
abluminal side of arterial blood vessels (190, 191). One investigation has reported the
existence of pericytes in the marrow (19) but other reports have concluded that there are
no pericytes in the bone marrow (191, 194). It is difficult to propose that the cells
isolated here are pericytes since the existence of pericytes in the marrow is controversial.
Some investigators have stated that the large stromal cells in LTBMC-M cultures
are endothelial in origin (96). Expression of a-actin also makes it unlikely that these
stromal cells are endothelial, although VCAMl has been reported on marrow sinus
endothelium (196).

Fresh stromal cells do not stain with the lectin Ulex europaeus

agglutinin I (UEA)(data not shown), a marker used to identify endothelial cells in other
tissues (196-198). However, UEA does not label endothelium in the marrow (199,200)
so conclusive discrimination of these stromal cells from endothelial cells will require a
more definitive marker of marrow endothelium.

An antibody against angiotensin-
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converting enzyme has been described as a marker for endothelial cells and may enable
discrimination of stromal cells from endothelial cells (201).

The coexpression of

VCAMl, commonly seen on activated endothelial cells, and a-actin, a smooth muscle
characteristic, makes it possible that stromal cells represent a unique lineage with a
phenotype intermediate between endothelial cells and smooth muscle.

Further

investigation with more definitive lineage markers and the discovery of a stromal cell
marker would help explore this possibility.
CYTOKINE PROTEIN EXPRESSION BY STROMAL CELLS
Analysis of cytokine protein expression by these stromal cells yielded some
interesting comparisons to in vitro cultured stromal cells. First, IL-7 appeared to be
expressed by nearly all freshly isolated stromal cells. This is surprising in light of the
fact that B lineage cells comprise only about 25 % of marrow cells and IL-7 responsive
B cells are only a small subset of that. It is known that young adult mice, such as those
used in my studies, are preferred for setting up LTBMC-B cultures and have active
lymphopoiesis (105,173,174). This may explain the widespread expression of IL-7 by
stromal cells in young mice. However, the rate of lymphopoiesis slows in older mice
(202,203), possibly due to decreased expression of IL-7 by stromal cells in older mice,
a question amenable to study by the methods described here. No cells stained for IL-7
protein among the VCAMl· cells, suggesting that IL-7 staining is a stromal cell specific
marker.
Kit ligand has broad hemopoietic effects (38,39,52-58,180-182) but was only
found in about half of the stromal cells. The function of KL as only an accessory factor
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in B cell formation, as well as its potent effects as a synergistic factor in combination
with other hemopoietic cytokines, may mean that widespread expression of KL is not
essential. Rather, small, focal amounts may be more effective. Nevertheless, this is the
first report of KL expression by stromal cells in the marrow; previous studies have found
expression of kit ligand on cultured stromal cells and extrapolated its in vivo function
from that data (38,39,52-60,206). Similarly to IL-7, no cells stained for KL protein in
the VCAMl- fraction.
A particularly revealing comparison between these uncultured stromal cells and
cultured stromal cells is the expression of M-CSF. M-CSF is expressed constitutively
by

primary

cultured

stromal

cells

and

by

all

stromal

cell

lines

(3,63,64,120,121,122,129). Based on this data, it has been suggested that M-CSF
production by stromal cells is important in vivo, possibly to maintain resident marrow
macrophages (122). Very few freshly isolated stromal cells possess detectable M-CSF
protein, suggesting that M-CSF expression by cultured stromal cells may be induced by
culture conditions. As well, endothelial cells are known to produce M-CSF. A small
contamination of the stromal cells with endothelial cells could explain the M-CSF
staining, meaning that possibly no stromal cells possessed M-CSF protein. About 2 %
of the VCAMl- cells stained positively for M-CSF protein. These positive cells were
determined to be monocytes by morphology.
These cytokine studies establish a baseline expression of three hemopoietic
cytokines by marrow stromal cells in young mice. Some evidence suggests that the rates
of lymphopoiesis and myelopoiesis are inversely related. It may, therefore, be useful to
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study changes in cytokine production in times of hemopoietic recovery as in irradiation
or after treatment with cytotoxic drugs such as 5-fluorouracil (44,205).

Bone marrow aggregates represent nonnal associations of stromal cells with specific
stages of hemollymphopoiesis.
These studies focused on the frequency of cells in aggregates because an increase
in frequency means that cells were not randomly distributed throughout the marrow, but
selectively retained in one fraction or the other. Since aggregates contain such a small
proportion of total marrow cells they would be expected to contain only a minor fraction
of the absolute number of any given cell type.

Enrichment of cells of a particular

differentiation stage within the aggregates implies a necessity for contact or close
association with stromal cell processes, which interdigitate through the aggregates. Other
cell types examined were found to be present in equal frequency in aggregates and in
unfractioned marrow, meaning that the distribution of these cells is random within the
marrow. Alternatively, the dissection of the cell populations may not be discrete enough
and subpopulations of certain stages may be sequestered in aggregates.

Additional

markers for B lymphocyte development would allow for better scrutiny of cells requiring
stromal cell contact. Potentially, the cells in aggregates could, in and of themselves,
define subsets of marrow populations. For example, differences in proliferative activity,
marrow repopulating ability, or mobility of stem cells may exist. It must also be noted
that previous analysis of bone marrow, with a few exceptions (105,144,145,192), has
neglected the existence of cell aggregates, potentially biasing results concerning stem cell
populations.
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Figure 22.

Scheme of hemopoietic cell-stromal cell contacts occurring in marrow

aggregates. Cells filled with hatched patterns are known to be enriched in aggregates (3,
this report). Open circles represent cells not enriched in aggregates. Arrows denote
differentiation pathways for hemopoietic cells. Cells thought be rearranging IgH (*)(31)
and IgL (**)(36) are indicated. CAFC 28, presumably the most primitive cell type
shown, give rise to more mature CAFC

and eventually to colony forming units

responsive to IL-3 and KL. Cells forming cobblestones in LTBMC-B conditions and B
lineage colonies in response to IGF-1 and IL-7 do not express B220(CD45RA) and are
therefore the most primitive B cell precursors shown. Although only one stromal cell
type is shown it is possible that different types of stromal cells exist in vivo.
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While it has not been definitively tested here, I believe that these aggregates are
present naturally within the marrow and may represent native intercellular associations.
It is unlikely that aggregates represent collapsed tissue sinuses in the marrow.

Intact

marrow sinuses are filled with IgM+ B cells awaiting egress from the marrow (68) and,
if collapsed in our marrow preparations, would be expected to be enriched in IgM+ cells.
'
Our aggregates, however, are actually depleted of sµ+

B cells, arguing against a

sinusoidal origin of the aggregates. Moreover, the aggregates are resistant to vigorous
pipeting or vortexing, procedures that would be expected to disrupt non-specific
interactions.

A tight association of the cells is implied by the comparatively harsh

collagenase conditions used, which are the minimum required to completely disperse the
clusters.

The numbers of cells recovered in aggregates is remarkably constant from

experiment to experiment suggesting that they are a reproducibly isolated component of
the normal marrow. In addition, the reticular staining patterns reported for mAb M/K2
and alkaline phosphatase in whole marrow (67,113) is reproduced in isolated aggregates
(Fig. 1) supporting the belief that aggregates mirror the native architecture of regions
within the marrow. As well, disruption of the aggregates in vivo by injection of antiVCAMl antibody strongly suggests that the aggregates are present naturally.

VCAMl AS AN ADHESION MOLECULE IN THE MARROW
These results confirm a role for VCAMl in stromal-hemopoietic cell adhesion in

vivo. The failure of these experiments to disrupt all aggregates could be due to several
effects: 1) the amount of antibody injected was not optimal; 2) the time after injection
was not optimal; 3) not all stromal cells use VCAMl at any given time;_ 4) not all
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aggregates contain stromal cells (Chapter II). Moreover, the closure of sinusoids during
'lymphocyte loading' could decrease blood flow to localized regions of the marrow, thus
decreasing the local concentration of antibody and allowing some aggregates to escape
disruption over the short time span (68). The time after injection was chosen based on
previous reports showing that bone marrow cells could be efficiently labelled with
antibody as rapidly as 15 minutes after i. v. injection (147).

Although I have not

determined how much antibody remains in circulation when the marrow is harvested, I
consider it unlikely that such residual antibody leads to the aggregate disruption seen
here. The marrow is immediately flushed from the femur, in this process the original
marrow volume is diluted 20 to 30 fold. It is unlikely that such dilute antibody could
mediate aggregate disruption, particularly in light of attempts to see aggregate disruption
in vitro, which used 20µg/ml of antibody to see an effect. The aggregates that survived
anti-VCAMl antibody treatment contained stromal cells in frequency identical to that in
untreated control animals (data not shown). These remaining stromal cells could use
adhesion mechanisms other than VCAMl.

However, since the absolute number of

stromal cells in aggregates was reduced it is likely that some stroma1 cells were entirely
liberated from aggregates, implying that at any one time some fraction of stromal cells
may solely use VCAMl as an adhesion mechanism.
Only anti-VCAMl antibodies were tested in these studies because VCAMl seems
to be expressed on stromal cells and very little else in the marrow (113). VLA4, a
ligand for VCAMl, is expressed on a variety of cell types (116). For example, many
hemopoietic cells, including stem cells, express VLA4, a ligand for VCAMl,but in vitro
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these cells bind fibronectin as well as VCAMl + stromal cells (118, 119,206). Therefore,
using anti-VLA4, it would not be possible to attribute the disruption to either ligand.
Also, the presence of VLA4 on a high percentage of bone marrow cells would probably
necessitate a high dose of antibody to see effects.

Similar arguments also apply to

another stromal-lymphopoietic cell adhesion molecule, CD44(Pgpl), which is also
expressed on > 90% of bone marrow cells and can bind hyaluronate in the extracellular
matrix (114,117). Nevertheless, it is clear that many aggregates are held together by
mechanisms involving VCAMl and that this is an important adhesive interaction used by
stromal cells both in vivo as well as in vitro.

AGGREGATESAPPEARTOORIGINATEINTHESUBENDOSTEALMARROW.
A gradient of differentiated B lineage precursors exists in the marrow; the least
mature stages predominate in the peripheral, endosteal areas and more mature stages
reside in the central marrow, distal to the bone (31,44,45,207). Aggregates bear some
features that suggest that they originate primarily in the subendosteum. For example,
TdT+ cells are reported to constitute 4% of endosteal cells and to diminish to 0.7% as
one progresses toward the central marrow (45). These percentages are parallelled in our
data on aggregates and deaggregated marrow, respectively. The proliferative activity of
marrow, as assessed by 3H TdR incorporation and autoradiography, is also greater
peripherally than centrally (208). Again, this coincides with our results showing greater
3

H TdR incorporation by aggregate cells than deaggregated marrow.

The apparent

inconsistency between the marked increase in 3H TdR uptake and the modest increase in
percentage of cells in S + G2M in aggregates might be resolved by interpreting these
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results in the light of reports that endosteal cells, i.e. more primitive progenitors typified
by TdT+ cells, are proceeding through the cell cycle very quickly (173). Over the 18
hour pulse period used in these experiments such immature progenitors would, therefore,
go through more mitoses than more differentiated, less mitotically active cells present in
deaggregated marrow, thus incorporating more radioactive label. Therefore, it is entirely
plausible that aggregate cells, while containing only slightly more cells in S

+ G2M, are

actually capable of incorporating much more radioactive label than deaggregated marrow
cells.

STROMAL CELL-HEMOPOIETIC CELL ASSOCIATIONS
Since aggregates appear to represent normal associations in the marrow, I
attempted to dissect the stages of hemopoiesis that are enriched in aggregates. Such an
analysis should give clues to the stages of hemopoiesis that normally interact with stromal
cells in the marrow. The content of precursor cells within different hemopoietic lineages
in aggregates was analyzed because an increase in frequency means that cells were not
randomly distributed throughout the marrow, but were selectively retained in one fraction
or the other. The results of these studies are schematized in Figure 22, highlighting the
stages of hemo/lymphopoiesis that, by being enriched in the aggregates, may require
association with stromal cell processes. The most primitive CAFC (day 28) are proposed
to give rise to progressively more mature CAFC (days 21, 14, 7) and eventually to CFU-S
(25), which can proliferate in response to IL-3 and KL (180). In this scheme it is only
the CAFC that selectively interact with stromal cells.
The interactions of developing B cells appear to be more complex. The earliest
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detectable B cell precursors, those forming cobblestones after 14 days of culture under
lymphoid permissive conditions (CAFC-W/W) (177,209) and those responding to IGF-1
and IL-7 (40), do not appear to require stromal cell association. Cells expressing TdT,
and presumably undergoing IgH chain rearrangement (31), are enriched within aggregates
(Chapter II)).

Cells expressing lgµ chain in the cytoplasm (cµ+) are enriched in

aggregates but IL-7 responsive cells, a subset of cµ+ cells (34), are not enriched
(Chapter II).

Therefore we predict that a cµ+ cell that has proceeded past IL-7

responsiveness and may be undergoing IgL chain rearrangement requires stromal cell
association, as proposed by Melchers and colleagues (36). Although we show only one
stromal cell in this scheme it is entirely possible that multiple stromal cell types are
present within the aggregates and the associations shown may be specific to particular
stromal cell types.

DEVELOPMENT OF A QUANTITATIVE 'pro-B' CELL ASSAY
An important aspect of this work was the development of a quantitative assay for
very primitive B cell precursors. This work has shed new light on the effects of KL and
IGF-1 on B lymphocyte development. KL may not be obligate for B cell development
in homeostatic adult animals. For the most part, the synergistic activity of KL and IL-7

in vitro seems limited to increasing colony size rather than the number of colonies. This
was observed in 5 of 6 experiments. The increased number of colonies from B220+ cells
in experiment 2 still implies a role for KL in the B lineage. The presence of c-kit on a
small fraction of B220+ marrow cells (162) as well as on a number of B220+ cell clones
representing the earliest stages of B cell development (37,210) also implies that KL may
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act on the B lineage, but only as a proliferative costimulus with IL-7 after the onset of
B220 expression.

Treatment of normal animals with an antibody that inhibits c-kit

function leads to a massive increase in the percentage of B lineage cells in the marrow
(162), again arguing that KL is not essential to B lymphopoiesis. However, the status
of B cell development and function in KL or c-kit deficient Sl/Sf and W/W' animals
remains controversial (211-213). B cell precursor numbers are normal in the adult mice
but depressed in fetal liver, and marrow cells from W/W' animals are inefficient in
regenerating B cells in irradiated normal recipients (175, 176).
A colony assay for B220(CD45RAY B cell precursors in the bone marrow, based
on the work of Landreth et al. (40), was devised. This approach made it possible for us
to detect an earlier, possibly uncommitted, B cell precursor. Previously, the earliest B
cell precursor examined was the TdT+ stage, which is enriched within the aggregates
(Chapter II). Given this, it is puzzling that B220(CD45RAY B cell precursors responsive
to IGF-1 and IL-7 are not enriched in aggregates. These cells are reported to become
µ+within 48 hours of culture with IGF-1 and IL-7 (40) and presumably are predecessors
of TdT+ cells. It is unknown if these B cell precursors express TdT and proceed through
normal IgH chain rearrangement and N region addition in vitro.

There could be a

stromal cell specific interaction required to express TdT, explaining why TdT+ cells are
sequestered in aggregates while earlier B cell precursors are not. Alternatively, the
interaction between very early B lymphoid precursors and stromal cells could be more
labile.

A unique molecule, recognized by mAb KMI6, is found solely in areas of

lymphoid precursor interaction with stromal cell processes in the marrow (147). The
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tightness of this adhesion is unknown.
Muller-Sieburg et al. (177 ,209) has reported a limiting dilution system to detect
lymphoid restricted precursors, similar to the CAFC technique, using a single readout
time of 14 days. The relationship of this precursor to the cell responding to IGF-1

+

IL-7 is unclear, although neither cell expresses the B lineage antigen B220(CD45RA).
Using this lymphoid cobblestone assay (CAFC-W/W), I was again unable to find a
difference in the frequency of this cell between the aggregates and unfractioned marrow
(data not shown).

This strengthens the conclusion that many of the earliest B cell

progenitors are not sequestered in aggregates, but that specific stages of B cell genesis
are found, presumably requiring stromal cell signals at restricted points of
development.
DIFFERENTIAL REQUIREMENTS FOR ADHESION TO STROMAL CELLS
These results may reflect differential requirements for stromal cell contact by
myeloid and lymphoid progenitors. In this study early stem cells, culturable when in
contact with stromal cells, were found to be enriched in aggregates. Later stage cells,
capable of proliferation in soft agar culture without stromal cell contact, were not
enriched in aggregates, not were they specifically excluded.

This differential

sequestering may reflect less stringent binding of the nonenriched precursors by stromal
cells, making them more easily sheared off of the stromal cells. The diffusability of
growth factors and their activity when bound to extracellular matrix components could
make it unnecessary for some cells to be confined to stromal cells in aggregates
(214,215). Some cells might be excluded from the aggregates but are able to adhere
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nonspecifically to aggregates or they may settle into the aggregate fraction in stromal
cell-less clumps, increasing their apparent frequency.

They might also have an

intrinsically high density, causing them to settle into the aggregate fraction. The simplest
explanation, and probably the most likely, is that these cells are randomly distributed
throughout the marrow and partition equally into both aggregates and deaggregated
fractions.
Aggregates do not exclusively retain all cells of any given differentiation stage.
Cells not retained by the aggregates could be striped off of stromal cells during the
isolation procedure or the stromal cell might be destroyed as the marrow is flushed from
the bone, liberating the attached cells. Alternatively, aggregates might define unique
subsets of marrow cells differing in activation state, marrow repopulating ability, or
proliferative potential.

Additional markers could help to further dissect the cells

contained in the aggregates.

FUTURE DIRECTIONS
The discovery that stromal cells are selectively entwined in cellular aggregates
that are also enriched in selected stages of hemopoietic development has allowed for a
novel means to study stromal cell interactions and marrow structure in situ. In addition
to summarizing a good deal of data on the hemopoietic steps shown to be enriched in
aggregates, the scheme presented in Figure 22 is a framework for future experiments.
For instance, experimental manipulations are available to deplete the marrow of
hemopoietic cells. Injection of retrovirally marked stem cells after such treatment would
allow them to be followed through development as they enter and leave the aggregates.
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This would allow a more discriminating analysis of stromal cell dependent steps as well
as an avenue to study cell migration within the marrow. Blaszek et al. reported that the
Hematon fraction was reduced in patients with myelodysplastic syndromes or myeloid
leukemias (145). Similarly, the fraction of marrow cells present in aggregates might be
used as an indicator of marrow health.
Changes in cytokine production during marrow regeneration could be studied
using the methods described in the dissertation, allow the relative importance of cytokines
to be assessed. For instance, treatment of animals with 5-fluorouracil (5-FU) rapidly
depletes hemopoietic cells from the marrow (205). The marrow then repopulates each
lineage of hemopoietic cells in a characteristic order. Stromal cells could be isolated and
their cytokine production analyzed to see if the pattern of cytokine production changes
as each of the blood cell lineages repopulates. In addition, it has recently been reported
that lymphopoiesis decreases as mice age (202,203). The mechanism of the decrease is
unknown but it could be due to a decreased production of lymphopoietic cytokines by
stromal cells. Study of fresh stromal cells as reported here would be a way to test this
hypothesis.
This dissertation has yielded new insights into a number of areas of hemopoiesis.
First, the study of the stromal cell enriched bone marrow aggregates has provided a new
model to study marrow structure and stromal cell-hemopoietic cell interaction in vivo.
Second, the identification and enrichment of stromal cells directly from the marrow
allows the study of stromal cells without the caveats of cell changes during culture.
Third, these results demonstrate that stromal cells in vivo produce hemopoietic cytokines,
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similar to those found in LTBMC-B cultures. Fourth, the development of a quantitative
assay for B22o- B cell progenitors will allow other investigators to study very early stages
of B lymphopoiesis. This dissertation not only provides new data about marrow structure
and stromal cells, it provides many new avenues for future research into the control of
hemopoiesis.
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